Introduction {#s1}
============

Maintenance of proper brain function requires the balance of excitatory and inhibitory synaptic transmission. There is an increasing amount of evidence that the disruption of E/I balance in neural circuits is associated with neurological disorders, including autism, epilepsy and migraine ([@bib45]; [@bib73]). Several studies have proposed that impaired inhibitory function may drive a shift in E/I balance toward excitation, and underlie the phenotypic changes observed in these disorders ([@bib57]; [@bib35]). While animal model studies provide support for this hypothesis, our understanding of the molecular and cellular mechanisms that lead to E/I imbalance remains limited.

Mutations in the *CACNA1A* gene, which encodes the pore-forming α subunit of the CaV2.1 (P/Q-type) voltage-gated calcium channel (VGCC), are associated with a broad spectrum of autosomal dominant neurological disorders. CaV2 VGCCs are the predominant channels in presynaptic nerve terminals, where they mediate the Ca^2+^ influx that triggers the fusion of synaptic vesicles with the presynaptic membrane ([@bib12]; [@bib8]). *CACNA1A* mutations can cause episodic ataxia type 2 (EA2), epileptic seizures and familial hemiplegic migraine type 1 (FHM1) ([@bib49]). Episodic ataxia type 2 (EA2), whose clinical features include the lack of voluntary coordination of muscle movements and epileptic seizures, is associated with a range of missense, nonsense-, and splice site mutations throughout the *CACNA1A* gene. Familial hemiplegic migraine type 1 (FHM1), a severe variant of migraine that can co-occur with tonic-clonic seizures, has been found to be associated with missense mutations near the voltage sensors of the α1 subunit ([@bib1]). Electrophysiological analyses suggest that EA2 mutations lead to diminished channel functions, whereas both gain- and loss-of-channel function phenotypes have been reported for FHM1-associated mutations ([@bib10]; [@bib63]). Although these disorders have been conventionally distinguished, they exhibit considerable overlap in clinical presentations, leaving a precise correlation between genotype and phenotype unresolved.

Animal model studies can provide mechanistic insights into the pathology of *CACNA1A* mutations. Mice carrying FHM1 missense mutations R192Q or S218L in the *cacna1a* gene display gain-of-function CaV2 phenotypes with increased Ca^2+^ current density at lower voltages ([@bib65]; [@bib79]; [@bib70]). In FHM1 knock-in mice, glutamatergic neurotransmission in cortical pyramidal cells is enhanced, while GABAergic neurotransmission is unaltered. These findings suggest that FHM1 mutations cause a dysregulation of cortical E/I balance ([@bib73]).

The genome of the nematode *Caenorhabditis elegans* encodes a single CaV2α subunit gene*: unc-2* ([@bib56]). UNC-2/CaV2α is exclusively expressed in the nervous system ([@bib39]) and localizes to presynaptic zones, at synaptic vesicle release sites ([@bib55]), as well as at the plasma membrane of neural somas ([@bib20]). Behaviorally, *unc-2* loss-of-function (lf) mutants are sluggish and uncoordinated ([@bib39]). Furthermore, *unc-2(lf)* mutants have a reduced frequency of spontaneous excitatory postsynaptic currents (EPSCs) ([@bib52]), and a reduced intrinsic neuronal calcium oscillations of *C. elegans* motor neurons ([@bib20]).

In this study, we characterize a novel *unc-2/CaV2α* gain-of-function (gf) mutant, which, in sharp contrast to the loss-of-function mutant, exhibits hyperactive- as well as seizure-Iike motor behaviors. We show that the expression of an *unc-2* gene carrying FHM1 mutations results in a similar hyperactive behavioral phenotype, while the intragenic suppressor alleles of *unc-2(gf)* resemble EA2 mutations and are lethargic. We reveal that the *unc-2(gf)* mutation shifts the E/I balance toward excitatory transmission, and that increased excitatory signaling leads to the destabilization of GABAergic synapses in a TAX-6/calcineurin-dependent manner.

Results {#s2}
=======

*zf35* mutants are hyperactive {#s2-1}
------------------------------

*C. elegans* locomotion is biased toward sustained forward runs, interrupted by periodic brief reversals. From a forward genetic screen for animals with locomotion defects, we isolated a mutant, *zf35*, which failed to execute sustained forward or backward runs and continually switched the direction of locomotion in a jerky manner (reversal frequency: *zf35*: 43.1 ± 2.0/3 min, n = 59; wild type: 6.8 ± 0.4/3 min, n = 59) ([Figure 1](#fig1){ref-type="fig"}; [Video 1](#video1){ref-type="video"}). This clonic seizure-like phenotype of *zf35* mutants was accompanied by an increased locomotion rate during bouts of forward or backward locomotion. On average, *zf35* mutants moved approximately 1.5 fold faster than wild-type animals ([Figure 1A and B](#fig1){ref-type="fig"}). Animals heterozygous for the *zf35* mutation also displayed increased velocity and reversal frequency ([Figure 1A--C](#fig1){ref-type="fig"}), albeit to a lesser extent when compared to homozygous mutants. This indicates that the *zf35* mutation is semi-dominant. *zf35* mutant animals were slightly smaller than wild-type animals (0.82 ± 0.03 mm, n = 75 vs 1.00 ± 0.04 mm, n = 88) ([Figure 1D](#fig1){ref-type="fig"}) and had a reduced brood size (wild type: 207 ± 11, n = 5, *zf35*: 150 ± 16, n = 5). Furthermore, *zf35* adults retained a reduced number of eggs in the uterus (*zf35*: 3.6 ± 0.2, n = 86; wild type: 14.1 ± 0.6, n = 80) ([Figure 1E](#fig1){ref-type="fig"}). *zf35* mutants laid eggs that are at an earlier developmental stage than wild-type animals, indicating that the time between fertilization and egg laying was reduced ([Figure 1F](#fig1){ref-type="fig"}). Therefore, *zf35* mutants are hyperactive in both locomotion and egg-laying behaviors.

![*zf35* animals are hyperactive in both locomotion and egg-laying behaviors.\
(**a**) Representative traces from single worm tracking showing instantaneous velocity of indicated genotypes on OP50 thin lawn plates (see Materials and methods). Positive and negative values indicate forward and backward locomotion, respectively. Transition from positive to negative values indicates reversal events. (**b**) Shown is the average velocity for the wild-type (0.118 ± 0.01 worm lengths/s, n = 9), *zf35* (0.156 ± 0.01 worm lengths/sec, n = 10), *zf35* /+ (0.155 ± 0.01 worm lengths/s, n = 10) animals (**c**) Quantification of the reversal frequency in 3 min on regular OP50 plates: average reversal numbers made by wild type (6.8 ± 0.4 reversals, n = 59), *zf35* (43.1 ± 2.0 reversals, n = 59) and *zf35/+* (33.2 ± 1.6 reversals, n = 23). Error bars represent SEM for at least three trials. Statistical difference from wild type \*p\<0.05, \*\*\*\*p\<0.0001, one-way ANOVA with Dunnett's multiple comparisons test. Statistical difference between *zf35* and *zf35/+* \*\*p\<0.01, unpaired t-test. (**d**) Representative images of wild type and *zf35* animals. Average of midline lengths of the wild type: 1.00 ± 0.04 mm, n = 88 and *zf35*: 0.82 ± 0.03 mm, n = 75. Scale bar is 200 µm. (**e**) Representative Nomarski images of unlaid eggs in adult wild-type and *zf35* animals. Arrowheads indicate eggs; asterisk denotes the position of the vulva. The average numbers of eggs in the uterus: wild type (14.1 ± 0.6 eggs, n = 80), *zf35* (3.6 ± 0.2 egg, n = 86) animals. Scale bar, 50 µm. (**f**) Embryonic stages of freshly laid eggs of the wild type and *zf35* mutants. 43% of the laid eggs from *zf35* animals are at 1--16 cell stage, while only 5% from the wild type laid eggs are at 1--16 cell stage. Five independent trials with 75 animals for each genotype. Statistical difference from wild type \*\*\*\*p\<0.0001, Chi-squared test.\
10.7554/eLife.45905.003Figure 1---source data 1.Source data for [Figure 1](#fig1){ref-type="fig"}.](elife-45905-fig1){#fig1}

###### *unc-2(zf35)* mutants have an increased reversal frequency.

Videos of locomotor behavior of the wild-type and *unc-2(zf35)* animals on NGM agar plates with seeded OP50.

10.7554/eLife.45905.004

*zf35* mutant's hyperactivity is caused by a missense mutation in the *unc-2/CaV2α* gene {#s2-2}
----------------------------------------------------------------------------------------

We mapped the *zf35* mutation to the left end of chromosome X between genetic markers *lon-2* and *dpy-3*. This region contains a gene, *unc-2*, which encodes the α1 subunit of the *C. elegans* CaV2 voltage-gated calcium channel. Sequencing analysis of the *zf35* allele revealed a single-base transition ([G]{.ul}GAto [A]{.ul}GA) in the 17th exon of *unc-2* ([Figure 2A](#fig2){ref-type="fig"}). UNC-2/CaV2α consists of four homologous domains (I-IV) each containing six hydrophobic membrane-spanning segments (S1--S6, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). The *zf35* mutation results in a glycine to arginine substitution (G1132R) in the highly conserved intracellular linker between III-S6 and IV-S1 ([Figure 2B and C](#fig2){ref-type="fig"}). To determine if UNC-2(G1132R) in *zf35* mutant animals is sufficient to confer the hyperactive phenotype, we generated an *unc-2(zf35)* cDNA clone, which encodes the UNC-2/CaV2α(G1132R) protein. Pan-neuronal expression of the *unc-2(zf35)* transgene, in both wild-type and *unc-2* loss-of-function mutant (lf) backgrounds, induced hyperactive behavior similar to that of the *zf35* mutant. Transgenic overexpression of the wild-type *unc-2* cDNA rescued the uncoordinated and lethargic phenotype of *unc-2(lf)* mutants, but did not induce hyperactive behavior ([Figure 2E](#fig2){ref-type="fig"}). *unc-2(zf35)* mutants did not display obvious defects in neural morphology (data not shown). To determine if the *zf35* mutation affected UNC-2 localization, we generated transgenic animals carrying C-terminus GFP-tagged *unc-2(zf35)* cDNA. UNC-2(GF/G1132R)::GFP was observed in the cell soma, and in puncta along the neuronal processes ([Figure 2D](#fig2){ref-type="fig"}). The fluorescence expression pattern of UNC-2(GF/G1132R)::GFP animals displayed no obvious difference with that of a UNC-2(WT)::GFP transgene ([Figure 2D](#fig2){ref-type="fig"}) ([@bib55]). This indicates that UNC-2(G1132R) is properly processed and trafficked to presynaptic sites.

![*zf35* is a novel allele of the CaV2α subunit gene *unc-2*.\
(**a**) The genetic map and gene structure of *unc-2.* Coding sequences are represented as black boxes. The *zf35* allele is a single nucleotide transition ([G]{.ul}GA to [A]{.ul}GA) resulting in a glycine to arginine (G to R) amino acid substitution at position 1132. (**b**) Diagram of the secondary structure of UNC-2/CaV2α. UNC-2/CaV2α consists of four domains (I--IV) each containing six alpha-helix [t]{.ul}rans[m]{.ul}embrane (TM) segments (S1 -- S6). The UNC-2 (G1132R) mutation localizes in the intracellular loop between TM domain III and IV, indicated by the blue circle. Purple circles indicate positions of intragenic *unc-2(zf35)* suppressors, red circles indicate the location of human FHM1 mutations. (**c**) The G1132R mutation occurs in a highly conserved region of the CaV2α subunit. Amino acid alignment of C-terminus region of the transmembrane III alpha-helix segment 6 (III S6) and the beginning of the third intracellular loop of CaV2α subunits from human (*Homo sapiens,* CACNA1A), rainbow fish (*Poecilia reticulata,* cacna1a), fly (*Drosophila melanogaster,* Cacophony) and nematode (*C. elegans*. UNC-2). Identities are shaded in dark gray, similarities in light gray. Location of the G1132R mutation is indicated. (**d**) Representative images of GFP tagged UNC-2(WT) and UNC-2(GF/G1132) in the ventral nerve cord. Asterisks point the cell bodies of the motor neurons and arrows indicate the presynaptic sites. Both constructs are expressed under pan-neuronal promoter *tag-168*. Scale bar, 10 μm. (**e**) Quantification of the reversal frequency: wild type (6.6 ± 0.4, n = 70), *unc-2(zf35)* (43.3 ± 1.9, n = 65), *unc-2(e55lf)* (2.4 ± 0.2, n = 59), wild-type animals expressing *unc-2(wt)* transgene (7.5 ± 0.6, n = 10) and *unc-2(zf35)* transgene (33 ± 2.1, n = 22), and *unc-2(e55lf)* rescued with *unc-2(wt)* transgene (3.8 ± 0.7, n = 12) and *unc-2(zf35)* transgene (41.3 ± 3.6, n = 21). Error bars represent SEM for at least three trials with indicated totaling animals number. Statistical difference from wild type \*\*\*\*p\<0.0001, one-way ANOVA with Dunnett's multiple comparisons test. (**f**) Intragenic *unc-2(lf)* mutations suppress *unc-2(zf35)* hyperactive locomotion. Shown are numbers of thrashes in 30 s in M9 for the wild type (107.0 ± 14.0, n = 60), *unc-2(zf35)* (128.1 ± 13.5, n = 60), *unc-2(lf)* (4.8 ± 2.1, n = 57), *unc-2(zf35 zf109)* (6.9 ± 4.3, n = 53); *unc-2(zf35 zf113)* (5.6 ± 3.7 thrashes, n = 57); *unc-2(zf35 zf114)* (80.2 ± 9.9, n = 60); *unc-2(zf35 zf115)* (6.9 ± 3.8, n = 56); *unc-2(zf35 zf124)* (5.3 ± 3.1, n = 57); *unc-2(zf35 zf130)* (67.1 ± 22.5, n = 58); *unc-2(zf35 zf134)* (31.2 ± 17.9, n = 50). Error bars represent SEM. Statistical difference from *unc-2(zf35)* mutants unless otherwise indicated, \*\*\*\*p\<0.0001, one-way ANOVA with Tukey's multiple comparisons test.\
10.7554/eLife.45905.007Figure 2---source data 1.Source data for [Figure 2](#fig2){ref-type="fig"}.](elife-45905-fig2){#fig2}

Intragenic mutations suppress the *unc-2(zf35)* hyperactivity phenotype {#s2-3}
-----------------------------------------------------------------------

*unc-2* loss-of-function (lf) mutants are sluggish and exhibit reduced motor activities ([@bib39]). *unc-2(lf)* mutants are also slightly longer than wild type animals, most likely due to reduced muscle contraction. The contrasting phenotypes between *unc-2(zf35)* and *unc-2(lf)* mutants suggested that the *zf35* G1132R mutation is a rare gain-of-function mutation. If so, secondary, loss-of-function mutations in the *unc-2* locus should function as intragenic suppressors of the hyperactivity phenotype of *unc-2(zf35)*. From a screen of mutagenized *unc-2*(*zf35)* mutants, we identified seven intragenic suppressor alleles that harbor missense or non-sense secondary mutations in the *unc-2* gene ([Figure 2B](#fig2){ref-type="fig"}).

Four suppressors, *zf109, zf113, zf115* and *zf124* reverted the *zf35* hyperactivity phenotype to sluggish locomotion, similar to the canonical loss-of-function *unc-2(e55)* allele ([Figure 2F](#fig2){ref-type="fig"}). The *zf113*(W550stop) and *zf124*(*M1369stop*) alleles result in premature stop codons and therefore likely represent null alleles of *unc-2*. The *zf115*(C341Y) and *zf109*(L1355F) missense mutations result in substitutions of conserved amino acids in the S5-S6 loop of domain I and IV, respectively. Two suppressors, *zf134* and *zf130*, caused moderate locomotion defects. The *zf134*(I970T) mutation affects an amino acid in the conserved voltage sensor, and the *zf130*(G1475D) mutation affects the C-terminal region, between a conserved EF-hand and the IQ-like motif. One suppressor, *zf114*(D892N), which changes an amino acid in the domain III S2, restored locomotion behavior of *unc-2(zf35)* to approximately wild-type levels. These intragenic suppressors represent an allelic series of hypomorphic *unc-2* mutations. Their ability to revert the hyperactive phenotype of *zf35* mutants to that of the wild-type or *unc-2(lf)* mutants strongly suggest that the *zf35* mutation is a gain-of-function allele of *unc-2*. Therefore, from here on the *unc-2(zf35)* allele will be referred to as *unc-2(zf35gf).*

A G to R substitution in CaV2α intracellular III-IV linker leads to increased CaV2 channel activity {#s2-4}
---------------------------------------------------------------------------------------------------

To investigate the functional consequences of the UNC-2/CaV2α G1132R gain-of-function mutation, we introduced the corresponding change (G1518R) into the human P/Q type CaV2.1 channel α1 subunit, CACNA1A ([Figure 2C](#fig2){ref-type="fig"}). CaV2.1α expression constructs were transfected into a HEK 293 cell line that stably expresses the auxiliary β1c and α2δ subunits ([@bib48]). Whole-cell patch clamp experiments ([Figure 3A](#fig3){ref-type="fig"}) showed that the CACNA1A(G1518R) CaV2.1α channel exhibited a −10 mV shift in activation potential when compared to the wild-type CaV2.1α channel ([Figure 3B and C](#fig3){ref-type="fig"}). The maximal current density was 1.7-fold larger for G1518R channels (80.6 ± 5.7 pA/pF, n = 11) compared to wild type (47.5 ± 4.3 pA/pF, n = 13) ([Figure 3B](#fig3){ref-type="fig"}).

![The UNC-2(G1132R) corresponding mutation in human CACNA1A, CaV2.1α, subunit results in increased channel activity.\
(**a**) Representative macro-currents of wild type and G1518R CaV2.1 channels. Currents were generated by stepping membrane potential to voltages between −55 and 40 mV in 5 mV increments for 200 ms from a holding potential of −120 mV. (**b**) Voltage dependence of whole-cell current density for wild type and G1518R CaV2.1 channels. Current density values were obtained by dividing current amplitudes and cell capacitance. (Wild type, n = 13; G1518R, n = 11). (**c**) Voltage dependence of Ba^2+^ current activation. The activation curve of G1518R exhibits a significant shift of the V~0.5~ value towards more negative membrane potentials. (**d**) Steady-State inactivation curves. The G1518R mutation causes a slight positive shift in the midpoint voltage in the steady-state inactivation curves (V~0.5inact~= -55.0 ± 1.0 and −47.3 ± 1.0 for wild type and G1518R, respectively). Currents were normalized to the maximal value obtained at the test pulse and plotted as a function of the prepulse potential. Data were fitted with the Boltzmann equation: (*I*~max~=(1+exp\[(V-V0.5)/kin\]) - 1). All recordings were carried out in Ba^2+^ solution to exclude the effects from calcium-dependent inactivation.\
10.7554/eLife.45905.009Figure 3---source data 1.Source data for [Figure 3](#fig3){ref-type="fig"}.](elife-45905-fig3){#fig3}

The slope of the activation curve was not significantly affected in the CACNA1A(G1518R) channel (K~a~WT = 3.8 ± 0.2 mV; K~a~ G1518R = 4.1 ± 0.1 mV, [Figure 3C](#fig3){ref-type="fig"}). Both wild-type and G1518R CaV2.1 channels decayed with similar mono-exponential time courses (T~inac~ CACNA1A(wt)=177 ± 45 ms and T~inac~ CACNA1A(G1518R)=196 ± 32 ms at a 0 mV pulse). This suggests that the transition from the open to the inactive states was not affected by the G1518R mutation. To determine if inactivation following closed states was altered, we compared steady-state inactivation properties of wild-type and G1518R channels ([Figure 3D](#fig3){ref-type="fig"}). The membrane potential at which half of the current was inactivated in the G1518R channels exhibited a 7.7 mV shift to more positive potentials compared to wild type (V~0.5inact~= -55.0 ± 1.0 mV and −47.3 ± 1.0 mV for the wild-type and G1518R channels, respectively). This displacement indicates that the proportion of activatable channels is increased for CACNA1A(G1518R) channels at a given membrane potential. Thus, the G1518R mutation leads to channels that are activated at lower membrane potentials, and inactivated at higher membrane potentials. Together, these properties lead to increased current density by CACNA1A(G1518R). The conservation in the linker between TM III and TM IV between *C. elegans* and mammals suggests that UNC-2(G1132R) exhibits similar gain-of-function effects in activation and inactivation kinetics of CaV2α channel. However, since these experiments were performed with the human CACNA1A channel in HEK cells, we cannot exclude the possibility that the corresponding UNC-2/CaV2α G1132R mutation may have different effects on channel function in *C. elegans*.

FHM1-analogous mutations in UNC-2/CaV2α lead to behavioral hyperactivity {#s2-5}
------------------------------------------------------------------------

Several missense mutations in the human *CACANA1A* gene result in familial hemiplegic migraine type 1 (FHM1) ([@bib49]). Electrophysiological analyses of the effects on CaV2.1 channel kinetics of FHM1 mutations in heterologous expression systems vary considerably and can even be contradictory. For instance, while some reports find that the R192Q mutation decreases CaV2.1 calcium transients ([@bib10]; [@bib63]), others find that the same mutation results in an increased calcium influx at lower membrane potentials ([@bib25]; [@bib69]). In knock-in mouse models, the R192Q and S218L, FHM1 mutations increased Ca^2+^ current density indicating a gain-of-function effect ([@bib69]; [@bib65]; [@bib70]). To determine the effects of FHM1 mutations in *C. elegans*, we introduced analogous R192Q and S218L mutations into *unc-2* ([Figure 4A](#fig4){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Pan-neuronal expression of the *unc-2(R192Q)* or *unc-2(S218L)* transgene in *C. elegans* resulted in phenotypes similar to *unc-2(zf35gf)* mutants. Specifically, both *unc-2(R192Q)* and *unc-2(S218L)* animals exhibited increased reversal frequencies (25.5/min ±0.9, n = 34 and 16.5/min ±0.9, n = 33, respectively) when compared to wild-type animals (4.2/min ±0.5, n = 29) ([Figure 4B](#fig4){ref-type="fig"}). They also displayed hyperactive egg-laying behavior ([Figure 4C](#fig4){ref-type="fig"}). *unc-2(FHM1)* transgenic animals laid eggs that are at an earlier developmental stage and retained fewer eggs in the uterus (*unc-2(R192Q)*: 5.7 ± 0.4, n = 37; *unc-2(S218L)*: 8.4 ± 0.6, n = 32, respectively), when compared to wild-type animals (16.5 ± 0.8, n = 23). These experiments provide strong genetic evidence that, similar to *unc-2(zf35)*, the FHM1 mutations are gain-of-function mutations that lead to increased CaV2 activity.

![FHM1 mutations in *unc-2* gene result in a hyperactive phenotype.\
(**a**) The amino acid alignment of the conserved region of transmembrane domain I membrane-spanning segments 4 (TM I S4) and the following linker region from human (CACNA1A) and worm (UNC-2) CaV2α subunits. Identities are dark gray and similarities are light gray. Indicated are the known human FHM1 mutations: R192Q and S218L. (**b**) Shown is the average number of reversals in 90 s on thin lawn OP50 plates: wild type (4.2 ± 0.5, n = 29), *unc-2(zf35gf)* (30.3 ± 1.2, n = 20), *Ptag-168::UNC-2(R192Q)* (25.5 ± 0.9, n = 34), and *Ptag-168::UNC-2(R192Q)* (16.5 ± 0.9, n = 33). (**c**) Average numbers of eggs in the adult uterus: wild type (16.5 ± 0.8 eggs, n = 23), *unc-2(zf35gf)* (2.7 ± 0.2, n = 35), *Ptag-168::UNC-2(R192Q)* (5.7 ± 0.4, n = 37), and *Ptag-168::UNC-2(S218L)* (8.4 ± 0.6, n = 32). Each bar represents the mean ± SEM for at least three trials with indicated totaling animals number. Statistical difference from wild-type, \*\*\*\*p\<0.0001, one-way ANOVA with Dunnett's multiple comparisons test. (**d**) Quantification of paralysis on 1 mM aldicarb. Each data point represents the mean ± SEM of the percentage of animals paralyzed every 15 min. 50% of the wild-type animals were paralyzed at 60 min. *unc-2(lf)* animals were resistant to the effects of aldicarb and reached 50% paralysis at 90 min. Homozygous *unc-2(zf35gf)* mutants were sensitive to aldicarb; 50% of the *unc-2(zf35gf)* mutants were paralyzed at 20 min. 50% of heterozygous *unc-2(zf35gf)* mutants paralyzed at 40 min. Three independent trials with at least 50 animals for each genotype; \*\*p\<0.01, \*\*\*\*p\<0.0001, two-way ANOVA with Tukey's multiple comparisons test. (**e**) Quantification of paralysis percentage on 1 mM aldicarb at the 60 min time point: 55.5% ± 4.5 of wild type, 56.7% ± 3.3 of *Ptag-168::UNC-2(WT)* and 98.3% ± 3.3 of *Ptag-168::UNC-2(GF)* expressed in wild-type animals, 27.1% ± 7.3 of *unc-2(lf)* animals, 54.8% ± 2.9 of *Ptag-168::UNC-2(WT)*, 100% of *Ptag-168::UNC-2(GF)*, and 100% of *Ptag-168::UNC-2(R192Q)* and *Ptag-168::UNC-2(S218L)* in *unc-2(lf)* background. \*\*p\<0.01, \*\*\*p\<0.001, one-way ANOVA with Dunnett's multiple comparisons test.\
10.7554/eLife.45905.011Figure 4---source data 1.Source data for [Figure 4](#fig4){ref-type="fig"}.](elife-45905-fig4){#fig4}

*unc-2/CaV2α* gain-of-function mutations increase sensitivity to aldicarb {#s2-6}
-------------------------------------------------------------------------

Our electrophysiological recordings suggested the UNC-2(GF/G1132R) channel may increase Ca^2+^ influx, resulting in elevated neurotransmitter release. To assess if *unc-2(zf35gf)* mutants have altered synaptic transmission, we analyzed their sensitivity to the acetylcholinesterase inhibitor, aldicarb. *C. elegans* body wall muscles receive input from excitatory cholinergic motor neurons ([@bib76]; [@bib53]). Aldicarb treatment causes the accumulation of acetylcholine (ACh), inducing muscle hypercontraction and acute paralysis ([@bib42]). Approximately 50% of wild-type animals exposed to 1 mM aldicarb became paralyzed within 1 hr, consistent with previous findings ([@bib42]; [@bib39]), while less than 15% *unc-2(lf)* mutants were paralyzed within 1 hr ([Figure 4D](#fig4){ref-type="fig"}). In sharp contrast, almost 100% of *unc-2(zf35gf)* mutants became paralyzed within 30 min ([Figure 4D](#fig4){ref-type="fig"}). Heterozygous *unc-2(zf35gf)*/+ mutants also paralyzed more rapidly than the wild-type, confirming that the *unc-2(zf35gf)* mutation is semi-dominant.

Pan-neuronal expression of *unc-2(R192Q)* or *unc-2(S218L)* also induced hypersensitivity to aldicarb ([Figure 4E](#fig4){ref-type="fig"}). This hypersensitivity is not due to overexpression of the *unc-2* transgene because expression of a wild-type *unc-2* transgene, which restored the locomotion defects in *unc-2(lf)* mutants, led to wild-type sensitivity to aldicarb ([Figure 4E](#fig4){ref-type="fig"}). Therefore, animals with gain-of-function mutations in *unc-2/CaV2α* are hypersensitive to aldicarb, which may reflect increased ACh release at the neuromuscular junction (NMJ).

*unc-2(zf35gf)* mutants exhibit increased cholinergic and decreased GABAergic spontaneous postsynaptic currents (sPSCs) at the neuromuscular junction {#s2-7}
-----------------------------------------------------------------------------------------------------------------------------------------------------

To directly assay the effect of the *unc-2(zf35gf)* mutation on synaptic function, we measured the frequency of spontaneous neurotransmitter release events in recordings of postsynaptic currents (PSCs) from *C. elegans* body wall muscles. *C. elegans* body wall muscles are innervated by both excitatory (cholinergic) and inhibitory (GABAergic) motor neurons ([@bib76]; [@bib40]; [@bib32]), To examine the total spontaneous PSC events, we performed recordings under conditions where both cholinergic and GABAergic PSCs appear as inward currents (−60 mV holding potential, see Material and methods). *unc-2(zf35gf)* mutants showed an over two-fold increase in the overall frequency of spontaneous PSCs when compared to wild-type animals ([Figure 5A and B](#fig5){ref-type="fig"}), with no significant changes in the mean amplitude ([Figure 5A and C](#fig5){ref-type="fig"}).

![The *unc-2(zf35gf)* mutation leads to increased spontaneous EPSCs and decreased spontaneous IPSCs.\
(**a**) Representative traces of total spontaneous postsynaptic currents (sPSCs) from ventral body wall muscles in wild-type and *unc-2(zf35gf)* mutants. (**b and c**) Mean spontaneous PSC frequency and amplitude of wild-type and *unc-2(zf35gf)* mutants. (**d**) Representative traces of spontaneous cholinergic EPSCs in *unc-49* and *unc-49; unc-2(zf35gf)* mutants. (**e and f**) Mean spontaneous EPSC frequency and amplitude *unc-49* and *unc-49; unc-2(zf35gf)* mutants. (**g**) Representative traces of spontaneous GABAergic IPSCs in wild-type and *unc-2(zf35gf)* mutants. (**h and i**) Mean IPSC frequency and amplitude of wild-type animals and *unc-2(zf35gf)* mutants. Error bars depict SEM. \*p\<0.05, \*\*p\<0.01, two-tailed Student's t test.\
10.7554/eLife.45905.013Figure 5---source data 1.Source data for [Figure 5](#fig5){ref-type="fig"}.](elife-45905-fig5){#fig5}

Since excitatory and inhibitory neurotransmitter systems appear to be differentially affected in FHM1 mouse models ([@bib65]; [@bib71]; [@bib72]), we analyzed the effect of the *unc-2(zf35gf)* mutation on cholinergic and GABAergic transmission. To isolate cholinergic currents, we performed recordings at a holding potential of −60 mV in the GABA receptor/*unc-49* mutant background. The frequency of spontaneous excitatory postsynaptic currents (EPSCs) was increased by approximately 1.5-fold in *unc-2(zf35gf); unc-49* double mutants compared with control *unc-49* single mutants ([Figure 5D--F](#fig5){ref-type="fig"}). To isolate spontaneous GABAergic inhibitory postsynaptic currents (IPSCs), we performed recordings in the presence of 0.5 mM d-tubocurarine at a holding potential of −10 mV, a condition that specifically eliminates EPSCs ([@bib38]). The frequency of spontaneous IPSC was reduced by half, without significant changes in the amplitude ([Figure 5G--I](#fig5){ref-type="fig"}).

Our data show that, despite being expressed by both cholinergic and GABAergic motor neurons, the *unc-2(zf35gf)* mutation leads to increased cholinergic and decreased GABAergic transmission to body wall muscles. Thus, instead of causing a uniform increase of neural signaling, the UNC-2/CaV2α(GF) mutation differentially affects excitatory and inhibitory signaling, shifting the E/I balance toward excitatory transmission.

*unc-2(zf35gf)* differentially affects excitatory and inhibitory synapses {#s2-8}
-------------------------------------------------------------------------

How does an increase of UNC-2/CaV2α activity lead to an E/I imbalance? Since changes in neuronal activity can modulate synaptic protein distribution ([@bib17]; [@bib68]), we examined the morphology of pre- and post-synaptic markers at cholinergic and GABAergic NMJs ([Figure 6](#fig6){ref-type="fig"}). We labeled cholinergic NMJs with the presynaptic vesicle marker RAB-3::mCherry (*Pacr-2*::RAB-3::mCherry) and the postsynaptic nicotinic ACh receptor (AChR) UNC-29::GFP (*Punc-29*::UNC-29::GFP) ([Figure 6A--D](#fig6){ref-type="fig"}). RAB-3::mCherry puncta were larger in *unc-2(zf35gf)* mutants ([Figure 6A and B](#fig6){ref-type="fig"}), consistent with the notion that increased calcium influx can recruit more synaptic vesicles to release sites ([@bib60]). Importantly, we also observed a marked increase in the size of UNC-29::GFP clusters, indicating a concomitant increase in the postsynaptic receptors ([Figure 6C and D](#fig6){ref-type="fig"}). To pharmacologically test if the increase in UNC-29::GFP fluorescence reflects an increase in the expression of functional AChRs at the cell surface, we examined the response of *unc-2(zf35gf)* mutants to an AChR agonist, levamisole. Levamisole induces hyper-contraction and paralysis through the activation of a class of UNC-29-containing AChRs in body wall muscles ([@bib32]). *unc-2(zf35gf)* mutants were hypersensitive to levamisole, consistent with an increased AChR expression on the muscle cell membrane ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). These pre- and postsynaptic morphological changes and pharmacological responses are consistent with the notion that the UNC-2/CaV2α(GF) mutation increases excitatory signaling to body wall muscle cells.

![*unc-2(zf35gf)* mutants have decreased GABA~A~ receptor expression at the NMJ.\
(**a and c**) Representative images of cholinergic synapses in wild type and *unc-2(zf35gf)* mutants. Presynaptic sites are labeled with synaptic vesicle marker RAB-3::mCherry while postsynaptic nicotinic acetylcholine receptors are labeled by UNC-29::GFP. Scale bar represents 10 μm. (**b and d**) Quantification of the fluorescence intensity of RAB-3::mCherry and UNC-29::GFP along the ventral nerve cord at cholinergic synapses in wild type and *unc-2(zf35gf)* animals. Arbitrary fluorescence units of individual animals are normalized to the mean value of the wild type. Normalized fluorescence of cholinergic RAB-3::mCherry: 0.99 ± 0.76, n = 21 in wild type and 1.36 ± 0.18, n = 14 in *unc-2(zf35gf)* mutants. UNC-29::GFP: 0.97 ± 0.05, n = 35 in wild type and 1.19 ± 0.06, n = 38 in *unc-2(zf35gf)* mutants. (**e and g**) Representative images of GABAergic synapses in wild type and *unc-2(zf35gf)* mutants. Presynaptic sites are labeled with synaptic vesicle marker RAB- 3::mCherry while postsynaptic GABA receptors are labeled by UNC-49::GFP. Scale bar represents 10 μm. (**f and h**) Quantification of the fluorescence intensity of RAB-3::mCherry and UNC-49::GFP along the ventral nerve cord at GABAergic synapses in wild-type and *unc-2(zf35gf)* animals. Arbitrary fluorescence units of individual animals are normalized to the mean value of the wild type. Normalized fluorescence of GABAergic RAB-3::mCherry: 1 ± 0.07, n = 18 in wild type and 1.25 ± 0.08, n = 20 in *unc-2(zf35gf)* mutants. UNC-49::GFP: 1 ± 0.09, n = 18 in wild-type and 0.75 ± 0.06, n = 20 in *unc-2(zf35gf)* animals. For all the quantification above, error bars depict SEM. \*p\<0.05, \*\*\*\*p\<0.0001, two-tailed Student's t test.\
10.7554/eLife.45905.022Figure 6---source data 1.Source data for [Figure 6](#fig6){ref-type="fig"}.](elife-45905-fig6){#fig6}

We observed a different effect on GABAergic NMJ morphology. We visualized GABAergic NMJs with the same presynaptic vesicle marker RAB-3 (*Punc-25*::RAB-3::mCherry) and the GABA~A~ receptor UNC-49 (*Punc-49*::UNC-49::GFP). In *unc-2(zf35gf)* mutants, RAB-3::mCherry puncta were enlarged, to a level comparable to that observed for cholinergic NMJs ([Figure 6E and F](#fig6){ref-type="fig"}). However, UNC-49::GFP puncta were severely reduced in both size and number ([Figure 6G and H](#fig6){ref-type="fig"}). In *unc-2(zf35gf)* mutants, RAB-3::mCherry puncta density was slightly increased, whereas UNC-49::GFP puncta density was reduced compared to wild type ([Figure 6---figure supplement 2](#fig6s2){ref-type="fig"}). At some NMJs, we noted the presence of RAB-3::mCherry puncta without punctate UNC-49::GFP apposition ([Figure 6---figure supplement 3](#fig6s3){ref-type="fig"}), suggesting post-synaptic silencing of GABA synapses.

The reduced UNC-49::GFP fluorescence in *unc-2(zf35gf)* mutants is in sharp contrast to the increased fluorescence of the UNC-29::GFP cholinergic receptor. RNA-seq experiments showed no obvious changes in the *unc-49* and *unc-29* expression level in wild-type *vs unc-2(zf35gf)* animals ([Figure 6---figure supplement 4](#fig6s4){ref-type="fig"}), suggesting post-transcriptional changes in UNC-49 and UNC-29 receptor localization and distribution. To determine if the morphological changes in UNC-49::GFP fluorescence signals reflect reduced levels of functional UNC-49 on the muscle cell surface, we analyzed *unc-2(zf35gf)* mutants' response to the GABA receptor agonist muscimol. Muscimol induces hyperpolarization of body wall muscles through UNC-49/GABA~A~-mediated inward Cl^-^ currents ([@bib53]). Muscimol sensitivity is assessed by the animal's ability to respond to head touch. Wild-type animals typically initiate backward locomotion when touched to their heads. After treatment with 1 mM muscimol, severely affected wild-type animals become flaccid, unable to respond to head touch. Moderately affected animals respond with a rubber band phenotype, in which the body wall muscles initially contract but then fully relax, failing to generate backward locomotion ([@bib14]). *unc-2(zf35gf)* mutants exhibited reduced sensitivity to muscimol: most *unc-2(zf35gf)* mutants were able to generate backward locomotion upon the head touch ([Figure 6---figure supplement 1B](#fig6s1){ref-type="fig"}). The partial resistance of *unc-2(zf35gf)* mutants to muscimol-induced muscle relaxation is consistent with reduction of UNC-49/GABA~A~ expression at the muscle cell surface.

Thus, consistent with the electrophysiological analyses, our pharmacological studies demonstrate that a gain-of-function mutation in UNC-2/CaV2α has distinct effects on cholinergic and GABAergic synapses. However, both spontaneous EPSC and IPSC amplitudes are not significantly different between *unc-2(zf35gf)* mutants and the wild type. This suggests that the density of functional cholinergic and GABAergic receptors at individual synapses is unchanged in *unc-2(zf35gf)* mutants. As individual synapses can be difficult to resolve with confocal microscopy, single fluorescent puncta often represent multiple synapses. Therefore, the synaptic fluorescence changes we observe most likely indicate increases or decreases in the number of excitatory and inhibitory synaptic connections. An increased number of cholinergic synapses would account for the increased sEPSC frequency, the levamisole hypersensitivity, and increased UNC-29::GFP fluorescence intensity in the of nerve cord. Similarly, a reduced number of GABAergic synapses is consistent with a reduced spontaneous IPSC frequency, reduced sensitivity to muscimol, and reduced UNC-49::GFP fluorescence intensity in the nerve cord.

*unc-2(zf35gf)* expression in cholinergic neurons impairs GABA synapse formation {#s2-9}
--------------------------------------------------------------------------------

The striking difference in excitatory and inhibitory neuromuscular signaling in *unc-2(zf35gf)*mutants is surprising since both cholinergic and GABAergic neurons express *unc-2.* Why does a gain-function-mutation in the presynaptic CaV2 channel lead to a reduction in the number of GABAergic synapses? The simplest explanation is that cholinergic and GABAergic synapses respond differently to increased presynaptic activity. For instance, while increased ACh release may result in the increase of cholinergic synapses, increased GABA release may result in a homeostatic reduction of GABAergic synapses. To test this possibility, we analyzed the GABAergic synaptic markers in animals that specifically express the *unc-2(zf35gf)* transgene in GABAergic motor neurons (*Punc-47::*UNC-2(GF)) in a wild-type background. Expression in GABAergic motor neurons alone resulted in an increase in both presynaptic RAB-3::mCherry and post-synaptic UNC-49::GFP fluorescence ([Figure 7A and B](#fig7){ref-type="fig"}; [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}). *Punc-47::*UNC-2(GF) animals are partially resistant to aldicarb, indicative of increased GABAergic signaling onto the body wall muscles ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). Thus, the reduction of GABAergic synapses in *unc-2(zf35gf)* mutants is not a direct consequence of elevated GABAergic neuron activity. Instead, our results indicate that increased GABAergic motor neuron activity in principle leads to increases in both presynaptic and postsynaptic termini similar to that observed for cholinergic synapses.

![The reduction of GABA~A~ receptor in *unc-2(zf35gf)* mutants is dependent on nicotinic acetylcholine receptor mediated signaling.\
(**a and c**) Representative images of GABAergic post-synaptic sites labeled with UNC-49::GFP of indicated genotypes. Scale bar represents 10 μm (**b**) Quantification of the fluorescence intensity of UNC-49::GFP along the nerve cord. Arbitrary fluorescence units of individual animals are normalized to the mean value of wild type. Normalized UNC-49::GFP fluorescence: wild type (1 ± 0.06, n = 41), *unc-2(zf35gf)* (0.4 ± 0.07, n = 15), *Punc-47::UNC-2(GF)* (1.5 ± 0.12, n = 13), *Pacr-2::UNC-2(GF)* (0.7 ± 0.07, n = 16), *acr-12; unc-2(zf35gf)* (1 ± 0.11, n = 15) and *unc-29; unc-2(zf35gf)* (0.9 ± 0.07, n = 14). (**d**) Quantification of the fluorescence intensity of UNC-49::GFP along the nerve cord of indicated genotypes. Arbitrary fluorescence units of individual animals are normalized to the mean value of wild type. Normalized UNC-49::GFP fluorescence: wild type (1 ± 0.04, n = 82), *L-AChR(WT)* (1 ± 0.05, n = 22), *L-AChR(GF)* (0.8 ± 0.05, n = 23), *unc-2(zf35gf)* (0.6 ± 0.07, n = 36), *tax-6* (1.1 ± 0.06, n = 54), *tax-6; unc-2(zf35gf)* (1 ± 0.05, n = 29). For all the quantification above, error bars depict SEM. \*p\<0.05, \*\*\*\*p\<0.0001, one-way ANOVA with Dunnett's multiple comparisons. (**e**) Model: The UNC-2 gain-of-function mutation shifts the E/I balance to an excitation-dominant transmission through the destabilaztion of GABA synapses in a TAX-6/calcineurin-dependent manner (See text for explanation).\
10.7554/eLife.45905.030Figure 7---source data 1.Source data for [Figure 7](#fig7){ref-type="fig"}.](elife-45905-fig7){#fig7}

Previous studies showed that cholinergic signaling affects the development and transmission of GABAergic neurons ([@bib27]; [@bib6]). Therefore, increased cholinergic transmission in *unc-2(zf35gf)* mutants may negatively affect the formation of GABAergic synapses. Indeed, when we expressed *unc-2(zf35gf)* only in cholinergic neurons (*Pacr-2*::UNC-2(GF)), UNC-49::GFP fluorescence was reduced to a similar degree as in the *unc-2(zf35gf)* mutants ([Figure 7A and B](#fig7){ref-type="fig"}). Presynaptic RAB-3::mCherry fluorescence in GABAergic neurons was slightly increased in *Pacr-2*::UNC-2(GF) animals ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}), which may reflect increased stimulation of GABAergic motor neurons by cholinergic motor neurons. Expression of an *unc-2(zf35gf)* transgene in cholinergic motor neurons increased sensitivity to aldicarb, consistent with an expected increase in cholinergic signaling ([Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}). Together, these results suggest that increased activity of cholinergic motor neurons in *unc-2(zf35gf)* mutants is not only required but also causes the decrease in GABAergic synapses.

Increased excitatory signaling leads to calcineurin-dependent reduction of inhibitory synapses {#s2-10}
----------------------------------------------------------------------------------------------

How might increased cholinergic input lead to a reduction in GABAergic synapses? First, we examined whether reducing cholinergic synaptic transmission was sufficient to restore UNC-49::GFP expression in *unc-2(zf35gf)* mutants. ACR-12, expressed by cholinergic motor neurons, and UNC-29, expressed by body wall muscles, are subunits of ionotropic AChRs. The loss of ACR-12 reduces excitability of cholinergic motor neurons ([@bib27]; [@bib46]). Loss of UNC-29, a subunit of the levamisole-sensitive AChR, reduces cholinergic depolarization of body wall muscles ([@bib16]; [@bib53]). In both *unc-2(zf35gf); acr-12* and *unc-2(zf35gf); unc-29* mutants, UNC-49::GFP fluorescence was restored to wild-type levels ([Figure 7A and B](#fig7){ref-type="fig"}). This finding indicates that increased cholinergic input to body wall muscles is the primary signal for decreasing the number of GABA synapses. Cholinergic motor neurons simultaneously innervate body wall muscles and GABAergic motor neurons ([@bib76]). Both *acr-12* and *unc-29* are also expressed by GABAergic motor neurons, and play a role in cholinergic activation of not only body wall muscles, but also GABA motor neurons ([@bib46]; [@bib47]). However, GABA signaling is not required for UNC-49/GABA~A~R expression or localization in body wall muscles ([@bib19]). Together, these results suggest that increased cholinergic input to body wall muscles negatively regulates GABAergic postsynapse formation or stability.

To directly test this possibility, we examined UNC-49::GFP expression in animals where we specifically increased cholinergic input to body wall muscles. Muscle-specific expression of the hyperactive levamisole-sensitive AChR (L-AChR(GF)) containing gain-of-function mutations in L-AChR subunits UNC-29 and UNC-38, leads to increased excitation of body wall muscles, but no obvious defects in muscle structure or cholinergic synapses ([@bib7]). *L-AChR(gf)* transgenic animals exhibited normal presynaptic marker expression at GABAergic NMJs. However, similar to *unc-2(zf35gf)* mutants, postsynaptic UNC-49::GFP fluorescence was markedly reduced in *L-AChR(gf)* animals ([Figure 7C and D](#fig7){ref-type="fig"}). Transgenic expression of the wild-type L-AChR (*Pmyo-3*::L-AChR(wt)) did not affect UNC-49::GFP fluorescence. This indicates that increased cholinergic signaling onto muscles in *unc-2(zf35gf)* mutants negatively regulates GABAergic postsynapse formation.

Several studies with cultured hippocampal neurons suggest GABAergic receptors are modulated by excitatory neuronal activity. In particular, sustained high Ca^2+^ levels reduce inhibitory synaptic strength through a calcineurin-dependent lateral diffusion of GABA~A~ receptor from synapses ([@bib3]; [@bib4]; [@bib43]). We examined whether *C. elegans* calcineurin, TAX-6, is required for the decrease in GABAergic postsynapses in *unc-2(zf35gf)* mutants. UNC-49::GFP expression was not significantly different in *tax-6(lf)* mutants ([Figure 7C and D](#fig7){ref-type="fig"}). However, the *tax-6(lf)* mutation restored UNC-49::GFP fluorescence in *unc-2(zf35gf)* mutants. *tax-6* is expressed in muscles and several neurons ([@bib30]). To determine whether *tax-6* is required in muscle, we performed RNAi feeding experiments. Most *C. elegans* neurons are resistant to RNAi feeding ([@bib28]; [@bib61]). *tax-6* RNAi feeding restored UNC-49::GFP fluorescence in *unc-2(zf35gf)* mutants ([Figure 7---figure supplement 3](#fig7s3){ref-type="fig"}), suggesting that TAX-6 acts in muscle to regulate GABA synapses. Together, these results indicate that increased cholinergic input to body wall muscles reduces the number of GABAergic postsynapses in a calcineurin-dependent manner.

Discussion {#s3}
==========

Gain- and loss-of-function mutations in *unc-2/CaV2α* result in opposing phenotypes {#s3-1}
-----------------------------------------------------------------------------------

Presynaptic voltage-gated calcium channels (CaV2) are crucial regulators of neuronal excitability and synaptic transmission. Here, we report the isolation of a gain-of-function mutation in the *unc-2* gene, which encodes the CaV2α subunit gene of *C. elegans. unc-2(zf35gf)* mutants are hyperactive and exhibit seizure-like motor behaviors, in contrast to the sluggish behavior of *unc-2(lf)* mutants ([@bib56]; [@bib39]). The *unc-2(zf35gf)* mutation results in a G-to-R substitution in a highly conserved region in the intracellular linker between TMIII and TMIV. Our electrophysiological analyses of the human CACNA1A channel in HEK cells indicate that this G-to-R substitution causes a shift to lower voltages of activation and reduced inactivation of the channel to increase Ca^2+^ influx. The increased current density of the CACNA1A(G1518R) channel could reflect increased channel conductance, and/or enhanced cell surface expression. We did not observe obvious differences in the expression and localization of the UNC-2(WT) and UNC-2(GF/G1132R) channel in *C. elegans.* This could suggest that this G-to-R substitution in the CaV2 channel may arise from an increased channel conductance. However, we cannot exclude that enhanced expression of the CACNA1A(G1518R) channel in HEK cells culture contributes to the increased current density. A similar G-to-R substitution in an intracellular linker of the human CaV1.2 channel results in similar defects in channel inactivation that underlies Timothy syndrome ([@bib58]). The negative shift in the activation potential of UNC-2/CaV2α(GF) channel is reminiscent of similar observations for several mutant human CaV2.1α channels that have been identified in patients with familial hemiplegic migraine type 1 (FHM1) ([@bib25]; [@bib64]; [@bib44]). While both loss- and gain-of-function phenotypes in CaV2.1 channels with FHM1 mutations have been reported in various expression systems, most FHM1 mutations appear to lead to channel activation at lower voltages and/or increased channel open probability. The gain-of-function effect of FHM1 mutations is supported by knock-in mouse models of the FHM1 R192Q and S218L channel, which activate at lower membrane potentials and have an increase in open probability ([@bib65]; [@bib70]).

Intragenic suppressor mutations of the *unc-2(zf35gf)* allele include both premature stop codons and missense mutations. Most intragenic suppressor mutations result in uncoordinated and lethargic phenotypes, indicating that they are hypomorphic alleles. Interestingly, some intragenic suppressor mutations resemble those found in CACNA1A in episodic ataxia type 2 (EA2) patients. The UNC-2(C341Y) mutation in the domain I S5-S6 loop is analogous to the CACNA1A(C287Y) mutation which was shown to alter channel trafficking and kinetics in whole-cell patch-clamp recordings of transfected COS-7 cells ([@bib74]), The UNC-2(L1355F) mutation in the domain IV S5-S6 loop analogous to CACNA1A (L1749P) mutation which was identified in a genome wide association study of EA2 patients ([@bib36]). These and other CACNA1A(EA2) missense mutations are partial or total loss-of-function mutations that lead to defects in channel trafficking or positive shifts in the voltage threshold for activation ([@bib26]; [@bib41]).

We found that expression of an *unc-2* transgene carrying FHM1 mutations R192Q and S218L in *C. elegans* recapitulated the behavioral hyperactivity of *unc-2(zf35gf)* mutants, whereas EA2-like CACNA1A(lf) mutations led to decreased motor activity. These studies provide strong genetic evidence that EA2 mutations are reduction-of-function mutations, while FHM1 mutations are gain-of-function mutations. *C. elegans*, which has a single CaV2α gene, thus provides an efficient in vivo system to determine the genetic nature of VGCC mutations associated with neurological disorders.

An *unc-2* gain-of-function mutation results in E/I imbalance {#s3-2}
-------------------------------------------------------------

Presynaptic Ca^2+^ influx through CaV2 channels is tightly coupled to neurotransmitter release. *unc-2* loss-of-function mutants are resistant to the acetylcholinesterase inhibitor aldicarb ([@bib42]), and have a reduction in spontaneous EPSC frequency ([@bib52]; [@bib62]; [@bib33]). The *unc-2(zf35gf)* mutation increases Ca^2+^ influx, which would lead to an increase in neurotransmitter release probability. In accordance, *unc-2(zf35gf)* mutants are hypersensitive to aldicarb, and show a two-fold increase in spontaneous EPSC frequency. In contrast, spontaneous IPSC frequency is significantly reduced in *unc-2(zf35gf)* mutants. Therefore, even though UNC-2 is expressed by both cholinergic and GABAergic motor neurons, the UNC-2/CaV2α(GF) mutation differentially affects excitatory and inhibitory signaling, shifting the E/I balance toward excitatory transmission.

Human studies indicate that cortical hyperexcitability in migraine patients ([@bib2]; [@bib50]), could result from enhanced excitation and/or reduced inhibition. This has led to the hypothesis that migraine is a disorder of brain E/I imbalance ([@bib73]; [@bib35]). Our data strongly support this hypothesis. The differential effect on excitatory and inhibitory signaling was also observed in FHM1 mouse models ([@bib65]). The R192Q FHM1 knock-in mice exhibit increased excitatory glutamatergic signaling, while inhibitory GABAergic transmission appears unaffected. In the R192Q FHM1 mice, an increase in glutamate release is thought to play a key role in initiation of cortical spreading depression, but the molecular and cellular mechanisms that underlie this E/I imbalance in mammals remain unclear. Our results provide new insights into how CaV2 gain-of-function mutations may lead to the E/I imbalances.

Increased excitatory transmission leads to destabilization of GABAergic synapses {#s3-3}
--------------------------------------------------------------------------------

The *C. elegans* neuromuscular system, where both excitatory (cholinergic) and inhibitory (GABAergic) motor neurons regulate muscle activity, provides a suitable and complementary model for mechanistic studies of E/I imbalance ([@bib59]; [@bib54]; [@bib79]). In our system, *unc-2(zf35gf)* mutations led to a modest increase in RAB-3 expression in the neurites of both excitatory and inhibitory motor neurons, consistent with the notion that increased Ca^2+^ influx may potentiate the recruitment of synaptic vesicles ([@bib23]; [@bib24]). However, the *unc-2(zf35gf)* mutation led to pronounced and opposite effects on the density of cholinergic and GABAergic receptors in the ventral nerve cord: an increase of AChR, but a marked decrease of GABA~A~R, which parallel the increased sEPSC frequency and reduced sIPSC frequency. Like the wild-type UNC-2/CaV2α, UNC-2/CaV2α(GF) channel proteins localize to presynapses to mediate Ca^2+^ influx and exocytosis of neurotransmitters so these effects are not attributable to channel mislocalization. Unchanged amplitudes of spontaneous EPSCs and IPSCs suggest the density of receptors at individual cholinergic and inhibitory synapse is not affected by *unc-2(zf35gf)*. Therefore, the differential density of cholinergic and GABAergic receptors and the frequency of spontaneous EPSCs and IPSCs likely reflects the number of functional synapses from excitatory and inhibitory motor neurons to the body wall muscles.

Our results show that the reduced GABAergic neuromuscular signaling in *unc-2(zf35gf)* mutants is a consequence of increased cholinergic signaling onto the same muscle target. A possible explanation of this observation is a differential response of cholinergic and GABAergic synapses to increased stimulation: strengthening of excitatory and homeostatic compensation of inhibitory synapses ([@bib37]; [@bib22]; [@bib18]). However, our results argue against this possibility: GABAergic-specific expression of the gain-of-function UNC-2/CaV2α channel leads to increased density of GABA~A~ receptors on the muscles, hence the CaV2(GF) channel in principle should increase synaptic strength in both synapse types. Our results instead reveal that the reduction of GABAergic neuromuscular signaling is a consequence of increased cholinergic input to the muscle cells.

In the mammalian brain, excessive neuronal excitation can induce long-term depression of GABAergic transmission ([@bib18]). Long-term depression of GABAergic transmission is associated with decreased GABA~A~ receptor clustering ([@bib3]). NMDA receptor mediated Ca^2+^ influx can induce LTD at GABAergic synapses by activating calcineurin ([@bib34]; [@bib75]). Sustained activity-dependent Ca^2+^ influx reduces inhibitory synaptic strength through a calcineurin-dependent increase in the lateral mobility of synaptic GABA~A~ receptors ([@bib3]; [@bib43]). GABA~A~ receptor clustering is regulated in part by lateral diffusion on the cell surface ([@bib66]), utilizing several evolutionarily conserved molecular mechanisms ([@bib38]; [@bib62]; [@bib67]). In *C. elegans*, increased AChR-mediated Na^+^/Ca^2+^ influx in *unc-2(zf35gf)* mutants may similarly affect GABA~A~ receptor stability to disassemble or prevent the assembly of GABAergic post-synapses. Increased excitatory signaling may thus lead to silencing of GABA synapses at the postsynaptic site, UNC-49/GABA~A~ receptor localization to postsynaptic sites is restored by removing TAX-6/calcineurin, implicating a conserved activity-dependent mechanism for modulation of synaptic inhibition.

We propose that UNC-2/CaV2 gain-of-function mutations change the E/I balance of the *C. elegans* neuromuscular system: increased excitatory signaling strengthens excitatory synapses, resulting in the destabilization of inhibitory synapses in a calcineurin-dependent manner [Figure 7E](#fig7){ref-type="fig"}. A decrease in synaptic inhibition has been implicated in epilepsy, schizophrenia and autism ([@bib15]; [@bib45]; [@bib73]). Since the role of CaV2 channels in excitatory and inhibitory signaling is conserved, the processes we describe provide valuable insights into molecular and neural mechanisms of E/I imbalance that underlie neurological disorders.

Materials and methods {#s4}
=====================

Strains {#s4-1}
-------

All strains were cultured at room temperature (22--24°C) on nematode growth media (NGM) agar plates with the *E. coli* strain OP50 as a food source. Experiments were performed on young adult animals (24 hr post-L4 larva) at room temperature (22--24°C). The wild-type strain was Bristol N2. Transgenic strains were obtained by microinjection of plasmid DNA into the germline with coinjection marker *lin-15* rescuing plasmid pL15EK both at 80 ng/µl into *unc-2(e55); lin-15(n765ts)* or *lin-15(n765ts)* animals unless stated otherwise. At least three independent transgenic lines were obtained for each injected construct. The data presented are from a single representative line. The following strains were utilized in this study:

Strains used in this study {#s4-2}
--------------------------

StrainFeatureGenotypeFiguresCB55canonical *unc-2* loss-of-function*unc-2(e55)*[Figure 2](#fig2){ref-type="fig"}, [Figure 4](#fig4){ref-type="fig"}QW37gain-of-function *unc-2unc-2(zf35gf)*All FiguresQW355*unc-2(zf35gf)* intragenic suppressor*unc-2(zf35gf zf109)*[Figure 2](#fig2){ref-type="fig"}QW359*unc-2(zf35gf)* intragenic suppressor*unc-2(zf35gf zf113)*[Figure 2](#fig2){ref-type="fig"}QW360*unc-2(zf35gf)* intragenic suppressor*unc-2(zf35gf zf114)*[Figure 2](#fig2){ref-type="fig"}QW441*unc-2(zf35gf)* intragenic suppressor*unc-2(zf35gf zf115)*[Figure 2](#fig2){ref-type="fig"}QW720*unc-2(zf35gf)* intragenic suppressor*unc-2(zf35gf zf124)*[Figure 2](#fig2){ref-type="fig"}QW726*unc-2(zf35gf)* intragenic suppressor*unc-2(zf35gf zf130)*[Figure 2](#fig2){ref-type="fig"}QW849*unc-2(zf35gf)* intragenic suppressor*unc-2(zf35gf zf134)*[Figure 2](#fig2){ref-type="fig"}QW383Pan-neuronal expression of UNC-2(GF)*lin-15(n765ts); zfEx51\[Ptag-168::UNC-2(GF); lin-15(+)\]*[Figure 2](#fig2){ref-type="fig"}, [Figure 4](#fig4){ref-type="fig"}QW388Pan-neuronal expression of UNC-2(GF) in *unc-2(lf)* background*unc-2(e55); lin-15(n765ts); zfEx51\[Ptag-168::UNC-2(GF); lin-15(+)\]*[Figure 2](#fig2){ref-type="fig"}, [Figure 4](#fig4){ref-type="fig"}QW392Pan-neuronal expression of UNC-2(WT) in *unc-2(lf)* background*unc-2(e55); lin-15(n765ts); zfEx51\[Ptag-168::UNC-2(WT); lin-15(+)\]*[Figure 2](#fig2){ref-type="fig"}, [Figure 4](#fig4){ref-type="fig"}QW1632Cell-specific expression of expression of UNC-2(GF) in GABAergic motor neurons*lin-15(n765ts); zfEx801\[Punc-47::UNC-2(GF); lin-15(+)\]*[Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}QW741Cell-specific expression of expression of UNC-2(GF) in cholinergic motor neurons*lin-15(n765ts); zfEx801\[Pacr-2::UNC-2(GF); lin-15(+)\]*[Figure 7---figure supplement 2](#fig7s2){ref-type="fig"}QW863Pan-neuronal expression of UNC-2(FHM S218L) in *unc-2(lf)* background*unc-2(e55); lin-15(n765ts); zfEx51\[Ptag-168::UNC-2(FHM1 S218L); lin-15(+)\]*[Figure 4](#fig4){ref-type="fig"}QW864Pan-neuronal expression of UNC-2(FHM R192Q) in *unc-2(lf)* background*unc-2(lj1); lin-15(n765ts); zfEx51\[Ptag-168::UNC-2(FHM1 R192Q); lin-15(+)\]*[Figure 4](#fig4){ref-type="fig"}QW1317Pan-neuronal expression of UNC-2(WT)::GFP in *unc-2(lf)* background*unc-2(e55); lin-15(n765ts); zfEx51\[Ptag-168::UNC-2(WT)::GFP; lin-15(+)\]*[Figure 4](#fig4){ref-type="fig"}QW1362Pan-neuronal expression of UNC-2(GF)::GFP in *unc-2(lf)* background*unc-2(e55); lin-15(n765ts); zfEx51\[Ptag-168::UNC-2(GF)GFP; lin-15(+)\]*[Figure 4](#fig4){ref-type="fig"}IZ930Synaptic marker strain for GABAergic synapses*ufIs58\[Punc-47::RAB-3::mCherry\]; oxIs19\[Punc-49::UNC-49::GFP\]*[Figure 6](#fig6){ref-type="fig"}, [Figure 7](#fig7){ref-type="fig"},\
[Figure 6---figure supplements 2](#fig6s2){ref-type="fig"} and [3](#fig6s3){ref-type="fig"},\
[Figure 7---figure supplements 1](#fig7s1){ref-type="fig"} and [3](#fig7s3){ref-type="fig"}IZ106Synaptic marker strain for nicotinic receptor*unc-29(x29); ufIs7\[Punc-29::UNC-29::GFP\]*[Figure 6](#fig6){ref-type="fig"}QW937Synaptic marker strain for GABAergic synapses in *unc-2(zf35gf)* background*unc-2(zf35gf); ufIs58\[Punc-47::RAB-3::mCherry\]; oxIs19\[Punc-49::UNC-49::GFP\]*[Figure 6](#fig6){ref-type="fig"}, [Figure 7](#fig7){ref-type="fig"}, [Figure 6---figure supplements 2](#fig6s2){ref-type="fig"} and [3](#fig6s3){ref-type="fig"},\
[Figure 7---figure supplements 1](#fig7s1){ref-type="fig"} and [3](#fig7s3){ref-type="fig"}QW1703Synaptic marker strain for GABAergic synapses *in unc-2(zf35gf);acr-12(lf)* background*unc-2(zf35gf); acr-12(ok367); ufIs58\[Punc-47::RAB-3::mCherry\]; oxIs19\[Punc-49::UNC-49::GFP\]*[Figure 7](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}QW1726Synaptic marker strain for GABAergic synapses *in unc-2(zf35gf);unc-29(lf)* background*unc-2(zf35gf); unc-29(x29); ufIs58\[Punc-47::RAB-3::mCherry\]; oxIs19\[Punc-49::UNC-49::GFP\]*[Figure 7](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}QW1367Synaptic marker strain for GABAergic synapses with cell-specific expression of UNC-2(GF) in GABAergic neurons*ufIs58\[Punc-47::RAB-3::mCherry\]; oxIs19\[Punc-49::UNC-49::GFP\]; zfEx609\[Punc-47::unc-2(zf35gf);+rol-6(+)\]*[Figure 7](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}QW1375Synaptic marker strain for GABAergic synapses with cell-specific expression of UNC-2(GF) in cholinergic motor neurons*ufIs58\[Punc-47::RAB-3::mCherry\]; oxIs19\[Punc-49::UNC-49::GFP\]; zfEx613\[Pacr-2::unc-2(zf35gf); rol-6(+)\]*[Figure 7](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}QW1849Synaptic marker strain for GABA~A~ receptor in *tax-6(lf)* background*tax-6(p675); oxIs19\[Punc-49::UNC-49::GFP\]*[Figure 7](#fig7){ref-type="fig"}QW1841Synaptic marker strain for GABA~A~ receptor in *unc-2(zf35gf);tax-6(lf)* background*unc-2(zf35gf); tax-6(p675); oxIs19\[Punc-49::UNC-49::GFP\]*[Figure 7](#fig7){ref-type="fig"}IZ539Synaptic marker strain for GABAergic synapses with body wall muscle expression of AChR(GF)*akIs26\[Pmyo-3::LEV-1(GF);Pmyo-3::UNC-29(GF); lin-15(+)(L-AChR(GF)\]; ufIs58\[Punc-47::RAB-3::mCherry\]; oxIs19\[Punc-49::UNC-49::GFP\]*[Figure 7](#fig7){ref-type="fig"}IZ818Synaptic marker strain for GABAergic synapses with body wall muscle expression of AChR(WT)*ufIs47\[Pmyo-3::UNC-38; Pmyo-3::UNC-29;Pmyo-3::LEV-1; lin-15(+) (L-AChR(WT)\]; ufIs58\[Punc-47::RAB-3::mCherry\]; oxIs19\[Punc-49::UNC-49::GFP\]*[Figure 7](#fig7){ref-type="fig"}

Molecular biology and plasmids {#s4-3}
------------------------------

The *unc-2(zf35gf)* mutation was introduced in the *Ptag-168::UNC-2(wt)* clone ([@bib55]) using site-directed mutagenesis. For cell-specific *unc-2(zf35gf)* transgene expression, cell-specific promoters for GABAergic (*Punc-47*) and cholinergic (*Pacr-2*) ([@bib5]) motor neurons were amplified by PCR with FseI restriction site at the 5' end and a AscI site at the 3' end. The *Ptag-168::UNC-2(zf35gf)* construct was digested with FseI and AscI to remove the *Ptag-168* promoter and replaced with cell-specific promoters of interest. To generate the *unc-2* transgenes carrying human FHM1 mutations (*UNC-2(R192Q)* and *UNC-2(S218L))*, the UNC-2 and human CACNA1A amino acid sequences were aligned to locate the corresponding amino acid substitutions in UNC-2/CaV2. The mutations were then introduced in the *Ptag-168::UNC-2(WT)* construct by site-directed mutagenesis. The wild-type human CaV2.1 cDNA used in the HEK cell recording was obtained from Y Cao and R Tsien ([@bib11]). To generate the human CaV2.1 G1518R cDNA, UNC-2 and human CACNA1A amino acid sequences were aligned to locate the corresponding UNC-2(GF) glycine(G) to arginine (R) substitution in CACNA1A. The mutation was then introduced in the *CACNA1A* cDNA by site-directed mutagenesis.

Isolation of *unc-2(zf35gf)* mutants, mapping and cloning {#s4-4}
---------------------------------------------------------

The *unc-2(zf35gf)* allele was isolated in a screen for animals that were resistant to the immobilizing effects exogenous tyramine as previously described ([@bib51]). We mapped *unc-2(zf35gf)* to LG X based on its hyperactive locomotion phenotype using SNP mapping ([@bib77]; [@bib13]). Three-factor mapping placed *unc-2(zf35gf)* to the left of *lon-2* and close to *dpy-3. *DNA sequencing of the *unc-2* gene was performed to identify the molecular change of *unc-2(zf35gf)* mutation.

Isolation and identification of intragenic *unc-2(zf35gf)* suppressors {#s4-5}
----------------------------------------------------------------------

*unc-2(zf35gf)* L4 animals (P0) were mutagenized with 0.5 mM N-ethyl-N-nitrosourea (ENU) for 4 hr. Approximately 10,000 F1 animals were bleached to obtain F2 eggs. F2 eggs were plated on NGM plates containing 0.25 mM aldicarb and examined for viable progeny after 7 and 14 days. Aldicarb resistant animals were individually transferred to fresh NGM plates, and their progeny were retested for aldicarb resistance. All suppressors isolated from the screen backcrossed with the wild-type N2. Suppressors that showed linkage to the X-chromosome were tested for complementation with *unc-2(e55lf)* mutants. Molecular changes of *unc-2(zf35gf)* intragenic suppressors were identified by DNA sequencing of the *unc-2* gene.

Behavioral and pharmacological assays {#s4-6}
-------------------------------------

Spontaneous reversal frequency was scored on NGM plates with freshly seeded OP50. The animals were transferred from their culture plate to a new plate, and allowed to recover for 1 min. After the recovery period the number of reversals was counted for 3 min. To quantify the instantaneous velocity and average forward velocity, animals were transferred from their culture plate to a new NGM plate seeded with a thin bacterial lawn and allowed to recover for 1 min. After the recovery period, the animals were tracked for 90 s using a single worm tracker ([@bib78]). Videos were recorded at 30 frames per second and each frame was analyzed with worm tracking software ([@bib31]) to measure instantaneous velocity of single animals. Reversals, as well as 10 frames before and following each reversal, were discarded from the average forward velocity.

To examine movement defects, individual young adult worms were transferred into 96-well plates containing 50 μl M9 buffer in each well. After a 30 s recovery period, body bends were counted for 30 s. A body bend was defined as a change in direction of bending at the mid-body.

Egg-laying assays were performed as described ([@bib29]). Rates of egg-laying behaviors were measured by two different assays: the numbers of unlaid fertilized eggs accumulated inside of adult animals, and the developmental stages of freshly laid eggs. Briefly, in both assays, L4 larvae were isolated and allowed to develop for 40 hr. In the first method, the adults were then incubated in 96-well plates containing 1% sodium hypochlorite until the bodies were dissolved. In the second method, the adults were transferred to a fresh plate. After 30 min, the developmental stage of each freshly laid egg was determined by viewing under a high-magnification dissecting microscope.

To quantify aldicarb and levamisole resistance, young adult animals were transferred to NGM plates supplemented with 1 mM aldicarb or 0.5 mM levamisole. The percentage of paralyzed animals was scored at 15 min intervals. Animals were scored as paralyzed when they did not move when prodded with a platinum wire. To assay muscimol response, young adults were transferred onto NGM plates containing 1 mM muscimol for an hour. The rubberband phenotype was subsequently scored by analyzing the behavioral response upon touching the animal with an eyelash across its body, (posterior to the pharynx) ([@bib14]). The rubberband response was classified in 4 categories of increasing severity. : 0, animals do not contract and relax but move away from the stimulus; 1, animals contract and relax and move away from the touch stimulus; 2, animals contract and relaxed and generate a small backward displacement (less than one-half of body length); 3, animals contract and relax but fail to move backwards; 4, animals incompletely contract and relax and fail to move.

Electrophysiology with HEK 293 cells {#s4-7}
------------------------------------

A stable HEK 293 cell line expressing the calcium channel auxiliary subunits β1c and α2δ ([@bib11]) was used to transiently transfect 5 μg of the wild-type or G1518R CaV2.1 α1 subunit using the calcium phosphate method. A plasmid encoding the green fluorescent protein (pGreen lantern) was also transfected to allow identification of transfected cells. Cells were cultured at 37°C in DMEM supplemented with 10% fetal bovine serum and 1000 U/ml penicillin--streptomycin.

Whole-cell inward currents were recorded 24--36 hr after transfection with a HEKA EPC-9 patch clamp amplifier. Recordings were filtered at 2 kHz and acquired using Patchmaster software (HEKA). The extracellular recording solution contained 5 mM BaCl~2~, 1 mM MgCl~2~, 10 mM HEPES, 40 mM TEACl, 10 mM glucose, and 87.5 mM CsCl, pH 7.4. Typically the pipettes exhibited resistances ranging from 2 to 4 MΩ and were filled with internal solution containing: 105 mM CsCl, 25 mM TEACl, 1 mM CaCl2, 11 mM EGTA, and 10 mM HEPES, pH 7.2.

Cell capacitance (16.7 ± 6.7 pF; n = 24) and series resistance (9.7 ± 4.6 MΩ before compensation; n = 24) were measured from the current transient after a voltage pulse from −80 to −90 mV. Series resistance was typically compensated by 80--90%. Cells with large currents in which errors in voltage control might appear were discarded. I-V curves were generated by measuring the peak currents obtained after stepping the membrane potential from a holding potential of −120 mV to voltages between −55 and 40 mV in 5 mV increments for 200 ms. I-V curves were fitted with Equation 1.: I = G(G -- E~rev~) (1+exp (V~0.5~- V)/ka)^−1^ where G is membrane conductance, E~rev~ is the reversal potential, V~0.5~ is the midpoint, and k~a~ the slope of the voltage dependence. Current densities were obtained by dividing the current peak amplitude to the cell capacitance for each experiment.

To measure steady-state inactivation profiles, conditioning pre-pulses (10 s) from −90 to 20 mV in 10 mV steps were applied, and the membrane was then stepped to the peak of the I--V curve. Currents were normalized to the maximal value obtained at the test pulse and plotted as a function of the prepulse potential. Data were fitted with Boltzmann equations: I/I~max~= (1 + exp\[(V-V0.5)/kin\]−1).

Data analysis was performed using the IgorPro software (WaveMetrics Inc, Lake Oswego, OR); figures, fitting and statistical analysis were done using the SigmaPlot software (version 11.0; Systat Software Inc). Data are presented as mean ± SD. Significant differences were determined using Student's t test with the significance value set at p\<0.01.

Electrophysiology with *C. elegans* neuromuscular preparations {#s4-8}
--------------------------------------------------------------

Total spontaneous postsynaptic currents were recorded from body wall muscles as previously described ([@bib21]). Intracellular solution: K-gluconate, 115 mM; KCl, 25 mM; CaCl~2~, 0.1 mM; MgCl~2~, 5 mM; BAPTS, 1 mM; HEPES, 10 mM; Na~2~ATP, 5 mM; Na~2~GTP, 0.5 mM cAMP, 0.5 mM; cGMP, 0.5 mM. pH 7.2 with KOH,\~320 mOsm. Extracellular solution: NaCl, 150 mM; KCl, 5 mM; CaCl~2~, 5 mM; MgCl~2~, 1 mM; glucose, 10 mM; sucrose, 5 mM; HEPES, 15 mM. pH 7.3 with NaOH,\~330 mOsm, and the membrane potential was held at −60 mV. To isolate spontaneous excitatory postsynaptic currents, total spontaneous postsynaptic currents were recorded in *unc-49/GABA~A~* receptor mutant background. To isolate spontaneous inhibitory postsynaptic currents, 0.5 mM d-tubocurarine (dTBC) was added to the extracellular solution to block acetylcholine receptors, and the membrane potential was held at −10 mV so IPSCs appeared as outward currents ([@bib38]). All electrophysiology experiments were carried out at room temperature (20--22°C).

Synaptic marker imaging {#s4-9}
-----------------------

L4-stage transgenic animals expressing synaptic markers were picked a day before imaging. Young adults were mounted on 2% agarose pads containing 60 mM sodium azide for 5 min and immediately examined for fluorescent protein expression and localization patterns. Only animals with ventral side facing the objective were imaged. Images were captured with a Olympus BX51WI spinning disk confocal microscope with a 63x objective in the region posterior to the vulva between DD4 and DD5 neurons. Individual slices from a single animal were projected into a single image using sum projection. Defined area containing the ventral nerve cord was cropped from each image and then subjected to auto threshold for fluorescence quantification in NIH ImageJ software. Arbitrary fluorescence units of individual animal were normalized to the mean value of wild-type animals that were taken on the same day. Each n represents analysis of the nerve cord from an independent animal.

RNAi experiments {#s4-10}
----------------

RNAi bacteria clones were streaked on LB-Amp Tet (Amp 100 μg/ml, Tet 12.5 μg/ml) plate and grown overnight at 37°C. Single colonies were picked from these plates and grown overnight at 37°C in LB Amp 100 μg/ml. Bacteria were concentrated to 4X and seeded on NGM RNAi plates containing 6 mM IPTG and 100 μg/ml Amp. Plates were dried overnight. Six L4 worms were transferred onto desired NGM RNAi plates for 24 hr to grow to adult. Adults were transfered to another NGM RNAi plate to set up limited egg laying time intervals to obtain age-synchronized animals for analyses.
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\[Editors' note: this article was originally rejected after discussions between the reviewers, but the authors were invited to resubmit after an appeal against the decision.\]

Thank you for submitting your work entitled \"Gain-of-function mutations in the UNC-2/CaV2α channel lead to excitation-dominant synaptic transmission in *C. elegans*\" for consideration by *eLife*. Your article has been reviewed by a Senior Editor, a Reviewing Editor, and three reviewers. The following individuals involved in review of your submission have agreed to reveal their identity: Ronald L Calabrese (Reviewer \#2).

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

As you will see from the reviews appended below, a major issue was the interpretation of the electrophysiology data. In particular, in the discussion following peer review, the concern was the conclusions based on the observed reduction in GABA synapse number without a concomitant change in mIPSC amplitude, especially since reduction in UNC-49 puncta intensity (using the same marker) has previously been shown to result in reduced mIPSC current amplitudes. Together with additional issues that were raised, the reviewers and editors concluded that this work would require extensive revisions and is better suited for a different journal.

*Reviewer \#2:*

The molecular and cellular mechanisms underlying this excitatory/inhibitory (E/I) imbalance seen in disease such as familial hemiplegic migraine are poorly understood. This work identifies a gain-of-function mutation, *unc-2(gf)*, in the *Caenorhabditis elegans* CaV2 channel α1 subunit (*unc-2* gene), which leads to increased calcium currents. Such mutants exhibit locomotor and egg-laying hyperactivity. Importantly expression of the *unc-2* gene with substitutions associated with familial hemiplegic migraine lead to hyperactivity similar to that of *unc-2(gf)* mutants. *unc-2(gf)* mutants show increased cholinergic and decreased GABAergic-transmission associated with a reduction of GABAergic synapses and an increase in cholinergic synapses. The authors also present evidence that the *unc-2(gf)* mutants lead to reduction of GABA synapses in a TAX-6/calcineurin dependent manner. Thus, this work has great general interest because it provides a roadmap and an experimental system for exploring mechanistic links between Ca-channel function and changes in E/I balance in the nervous system.

The paper is clearly written, and the figures present the data needed and do so clearly.

*Reviewer \#3:*

In this manuscript, Huang and colleagues, use *C. elegans* to decipher the cellular and neuronal circuit effects of a novel gain of function Ca^2+^ channel mutation. Furthermore, the authors present data to indicate that this novel mutation phenotypically resembles Ca^2+^ channel mutations found in familial hemiplegic migraine type 1. The study is significative because while it is known the in humans these types of mutations lead to increased excitation and reduced inhibition, the molecular underpinnings of this effect are unknown.

The study is in general rigorously designed; I have the following reservations though:

1\) The effect of the novel mutation the authors identified on Ca^2+^ currents was studied by introducing the mutation in the human homolog. The authors do not mention anywhere the percentage of identity and homology between the worm and the human *unc-2* type channels. This is relevant because, while the loop where the mutation is located is highly conserved, other parts of the proteins may not share such a high degree of homology and they may influence the overall effect of this mutation on the function of the channel. The experiment should really be repeated by introducing the mutation in worm *unc-2*.

2\) Throughout the text and in the figures, it is really hard to keep track of which gain of function mutation the authors are referring to. Is it the *unc-2(gf)* of the *unc-2/CaV2α(gf)*? Especially in light of the fact that exact parallelism between the worm and the human mutant channels function has not been firmly established, this point is particularly relevant. The authors should name the mutations throughout the text and in the figures and not simply call them *unc-2(gf)* mutants.

3\) It appears that the effect of the gain of function mutation is both on voltage dependence and either trafficking or single-channel conductance (or both, at least in expression system). Indeed, currents shown in Figure 3 were recorded under conditions of complete removal of inactivation (holding -120mV) yet the mutant currents are much larger than the wild type currents. The authors need to comment on this. The authors could also compare *unc-2(wt)::GFP* and *unc-2(gf)::GFP* to see if there is more mutant protein being expressed in vivo.

4\) While the results suggest that *tax-6* acts in the muscle to decrease GABAergic synapses, rescue or RNAi in muscle should confirm the conclusion of the authors.

*Reviewer \#4:*

The authors analyze a novel gain of function (gf) allele of CaV2 N-type calcium channels. The *unc-2(zf35gf)* mutant was isolated in a screen for altered locomotion, lacking persistent forward or reverse movements while retaining a high level of motility. Analogous mutations in mammalian CaV2 channels expressed in tissue culture cells shows that the *zf35* mutation alters channel gating (shifting activation to more negative membrane potentials and delaying inactivation). Similar gf alleles were previously described in mammalian CaV2 and CaV1 channels. Extensive analysis of *unc-2(zf35)* mutant worms finds changes in spontaneous cholinergic and GABAergic synaptic currents, and changes in the abundance of pre-synaptic (RAB-3) and post-synaptic (UNC-49 and UNC-29) markers. Based on these studies, the authors suggest that *unc-2(zf35gf)* mutants have altered GABA synapse development and that this results from the increased excitatory transmission. These conclusions are not strongly supported by the data. I agree that transmission has changed in these mutants, but it could simply be what you expect from increased UNC-2 channel currents. The analysis of *unc-2(gf)* mutants is extensive and would likely be of interest to *C. elegans* labs; however, they do not provide a clear understanding of how nervous system development or function is altered in these mutants. For these reasons, I do not support publication in *eLife*.

Essential revisions:

1\) Post-synaptic GABA receptor abundance was significantly reduced in *unc-2(gf)* mutants but this was not accompanied by a corresponding decrease in the amplitude of the spontaneous IPSCs. Several prior papers found that mutations decreasing GABA receptor puncta intensities are closely matched by similar changes in IPSC current amplitudes (e.g. Maro, Tu, and Tong papers). Given the absence of an effect on mIPSC amplitudes, these results suggest that the GABA receptors imaged here are non-synaptic. Altered non-synaptic receptors could be interesting but would require many new experiments to prove and document a functional consequence (e.g. altered tonic GABA inhibition).

2\) The authors conclude that *unc-2(gf)* mutants have decreased GABA synapse numbers, based on recordings indicating a decreased mIPSC rate. The mIPSC recordings were done in the presence of a cholinergic antagonist (dTBC), which by itself decreases mIPSC rate (since cholinergic neurons provide the excitatory input to GABA neurons). It seems possible that use of dTBC biases their results toward lower mIPSC rates. I recommend recording mIPSCs without dTBC (i.e. using a low chloride internal buffer and holding potentials of 0 mV).

3\) If lower synapse numbers occur in *unc-2(gf)* mutants (as the authors propose), I would expect that synaptic puncta density (both RAB-3 and UNC-49) would be reduced. The authors should report density data for the synaptic markers.

4\) If the *unc-2(gf)* mIPSC rate defect cell autonomous to D neurons? If so, one would not need to propose altered cholinergic transmission in causing this phenotype (which the authors propose).

5\) No controls are provided to determine if changes in synaptic puncta intensities are caused by transcriptional changes.

6\) The RAB-3 puncta intensity changes are hard to interpret without further experiments. Are other SV markers altered similarly? Is the SV pool size altered (either by electrophysiology or EM)?
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Author response

\[Editors' note: the authors' appeal in response to the first round of peer review follows.\]

> Reviewer \#3:
>
> In this manuscript, Huang and colleagues, use C. elegans to decipher the cellular and neuronal circuit effects of a novel gain of function Ca^2+^ channel mutation. Furthermore, the authors present data to indicate that this novel mutation phenotypically resembles Ca^2+^ channel mutations found in familial hemiplegic migraine type 1. The study is significative because while it is known the in humans these types of mutations lead to increased excitation and reduced inhibition, the molecular underpinnings of this effect are unknown.
>
> The study is in general, rigorously designed, I have the following reservations though:
>
> 1\) The effect of the novel mutation the authors identified on Ca^2+^ currents was studied by introducing the mutation in the human homolog. The authors do not mention anywhere the percentage of identity and homology between the worm and the human unc-2 type channels. This is relevant because, while the loop where the mutation is located is highly conserved, other parts of the proteins may not share such a high degree of homology and they may influence the overall effect of this mutation on the function of the channel. The experiment should really be repeated by introducing the mutation in worm unc-2.

We thank the reviewer for their comments. UNC-2 and mammalian CaV2 α1 subunit classes share highly similar (α1B = 73% similarity; α1A = 67%; α1E = 66%; Mathews et al. 2003). Since the similarity was published we did not include in the manuscript. We agree that this is helpful to directly compare UNC-2 and associated mutation directly with CACNA1a. Therefore, we will include an alignment of UNC-2 and CACNA1a in the supplemental figures.

The genetic data, and suppressor screen demonstrate that the *unc-2(zf35)* allele is a gain-of-function mutation of the CaV2α gene. We sought further evidence to demonstrate for the biophysical effect on channel function in cell transfection experiments. The HEK cell electrophysiology experiments show the effect of the G to R substitution on CaV2 channel function which is located in a highly conserved loop (Figure 2C). The main point of these experiments is to show that the G to R mutation results in a negative shift in voltage dependence activation, and increased current density similar to those observed for CACNA1a channels that carry FHM1 mutations. The HEK cell experiments are consistent with our behavioral-, electrophysiological and genetic analyses, clearly demonstrating that UNC-2(zf35) generates a gain-of-function phenotype. Analysis of the biophysical effect of the *zf35* mutation on the UNC-2/CaV2α channel would require the co-transfection of genes encoding the *C. elegans* ß (*ccb-1*) and α2∂ subunits (*unc-36*), and maybe other genes required for proper UNC-2 channel transport and localization *(e.g. calf-1)*. Unfortunately, no worm cell lines are available to perform these experiments. Mammalian cell lines stably transfected with ß and α2∂ subunits have been used extensively to study the effect of CaV2α mutations (including UNC-2 loss-of-function mutations; Mathews et al., 2003). This allowed us to make informative comparisons of the *zf35* mutation with those of previously characterized FHM1 mutations. The reciprocal experiment, expression of the *unc-2* transgene with corresponding human FHM1 mutations, provides strong behavioural and genetic evidence that FHM1 mutations are gain-of-function mutations.

> 2\) Throughout the text and in the figures, it is really hard to keep track of which gain of function mutation the authors are referring to. Is it the unc-2(gf) of the unc-2/CaV2α(gf)? Especially in light of the fact that exact parallelism between the worm and the human mutant channels function has not been firmly established, this point is particularly relevant. The authors should name the mutations throughout the text and in the figures and not simply call them unc-2(gf) mutants.

The *unc-2(gf)* refers to the *unc-2(zf35)* allele. We will clarify this and refer to the gain-of-function allele as *unc-2(zf35gf)* throughout the manuscript to avoid confusion. For the protein we will refer to it as UNC-2/CaV2α(GF).

*3) It appears that the effect of the gain of function mutation is both on voltage dependence and either trafficking or single-channel conductance (or both, at least in expression system). Indeed, currents shown in Figure 3 were recorded under conditions of complete removal of inactivation (holding -120mV) yet the mutant currents are much larger than the wild type currents. The authors need to comment on this. The authors could also compare unc-2(wt)::GFP and unc-2(gf)::GFP to see if there is more mutant protein being expressed* in vivo.

We agree with the reviewer that the larger currents that we show for the CaV2α(GF) channel could reflect increased single channel conductance, enhanced expression or both. We observed an increase in current density in independent transfection experiments in HEK cells (Figure 3). We did compare expression level, and localization of the UNC-2(wt)::GFP and UNC-2(gf)::GFP in transgenic animals (Figure 2D) and did not see any obvious differences. This suggests that the mutation, besides the change in the voltage dependence of activation, also affects conductance. We will explicitly mention these possibilities in the text.

> 4\) While the results suggest that tax-6 acts in the muscle to decrease GABAergic synapses, rescue or RNAi in muscle should confirm the conclusion of the authors.

We can perform this experiment to test the muscle requirement of *tax-6*.

> Reviewer \#4:
>
> The authors analyze a novel gain of function (gf) allele of CaV2 N-type calcium channels. The unc-2(zf35gf) mutant was isolated in a screen for altered locomotion, lacking persistent forward or reverse movements while retaining a high level of motility. Analogous mutations in mammalian CaV2 channels expressed in tissue culture cells shows that the zf35 mutation alters channel gating (shifting activation to more negative membrane potentials and delaying inactivation). Similar gf alleles were previously described in mammalian CaV2 and CaV1 channels. Extensive analysis of unc-2(zf35) mutant worms finds changes in spontaneous cholinergic and GABAergic synaptic currents, and changes in the abundance of pre-synaptic (RAB-3) and post-synaptic (UNC-49 and UNC-29) markers. Based on these studies, the authors suggest that unc-2(zf35gf) mutants have altered GABA synapse development and that this results from the increased excitatory transmission. These conclusions are not strongly supported by the data. I agree that transmission has changed in these mutants, but it could simply be what you expect from increased UNC-2 channel currents. The analysis of unc-2(gf) mutants is extensive and would likely be of interest to C. elegans labs; however, they do not provide a clear understanding of how nervous system development or function is altered in these mutants. For these reasons, I do not support publication in eLife.

We would like to respond to this reviewer's comments and clarify these issues with the editors. As pointed out by the reviewer 2 and 3, the main message of the paper is that gain-of-function mutation in the presynaptic voltage gated calcium channel causes an imbalance in E/I transmission. Since the *unc-2* is expressed in all neurons, this is not what would simply be expected from increased UNC-2 calcium currents. We present evidence that increased cholinergic transmission in *unc-2/CaV2α(zf35gf)* mutants leads to a reduction of GABA synapses in a TAX-6/calcineurin dependent manner. While additional detailed molecular and cellular mechanisms remain to be explored (as with any study), our data provide a deeper understanding of how alterations in Ca-channel function produce unexpected changes in E/I balance in the nervous system. Further, our analysis of FHM mutations using this model provides evidence that these mutations produce similar changes in E/I balance that have clear implications for human disease.

> Essential revisions:
>
> 1\) Post-synaptic GABA receptor abundance was significantly reduced in unc-2(gf) mutants but this was not accompanied by a corresponding decrease in the amplitude of the spontaneous IPSCs. Several prior papers found that mutations decreasing GABA receptor puncta intensities are closely matched by similar changes in IPSC current amplitudes (e.g. Maro, Tu, and Tong papers).

We understand the reviewer's point as there is currently some discrepancy in the field to what extent electrophysiological data correlate with fluorescence of synaptic markers.

However, the papers cited by the reviewer do not show that decreased postsynaptic GABAR marker signals are closely matched by changes in IPSC amplitude. Instead, consistent with our findings, these studies showed that decreased GABAR intensity is closed matched by a reduction in IPSC frequency. The IPSC amplitudes, even of the same mutant, behaved differently in different preparations, and the reported changes do not strongly correlate with reported changes UNC-49::GFP fluorescence.

To summarize the relevant data from these papers:

Maro et al. (2015) showed that the degree of reduction of UNC-49 puncta signals in *madd-4, nlg-1* and *nrx-1* mutants wereclosely matched by the reduction of the IPSC frequency. For example, *nlg-1* mutants exhibited strong reduction of IPSC frequency and UNC-49 signals, but *nrx-1* did not show defects in either. Here *nlg-1* mutants exhibited a very small reduction of IPSC amplitude, which did not closely match the very strong reduction in UNC-49/GABAR clustering and fluorescence.

Tu et al. (2015) reported reduction of mIPSC frequency and amplitude in these three mutants, irrespective of their different degrees of reduction of the UNC-49/GABAR fluorescence. For example, *madd-4B(0)* showed no significant change in UNC-49 intensity, but exhibited a significant reduction of IPSC frequency, and a milder reduction in amplitude.

Tong et al. (2015) also reported that the *nlg-1* mutants exhibited reduced UNC-49 fluorescence signals, reduced mIPSC frequency, and reduced mIPSC amplitude. The reduction in mIPSC amplitude reported in Tong et al. was larger than reported in the other two studies.

Tong et al. (2015) is the only paper that reported two other mutants (*lin-2, frm-3)* that exhibited a reduction in UNC-49/GABA receptor signals, reduced mIPSC amplitude reduction but no change in mIPSC frequency. Unlike *unc-2* mutants, these two genes function strictly in muscles to regulate UNC49/GABA receptor levels. In another mutant, *nrx-1*, which was examined also in the other two papers, the authors found no overt fluorescent marker change, but an increase of mIPSC amplitude and no change in frequency. The reported mIPSC amplitude changes don't follow an obvious trend with respect to changes in GABA receptor fluorescence intensity and are inconsistent across studies even for the same mutation.

Our results for *unc-2(gf)* mutants show concomitant changes of UNC-49/GABA receptor intensity and IPSC frequency, which is consistent with the most salient findings reported in the cited papers.

> Given the absence of an effect on mIPSC amplitudes, these results suggest that the GABA receptors imaged here are non-synaptic. Altered non-synaptic receptors could be interesting but would require many new experiments to prove and document a functional consequence (e.g. altered tonic GABA inhibition).

We report a decrease in UNC-49::GFP intensity in the ventral nerve cord of *unc-2(zf35)*, a decreased frequency of mIPSCs, and an unchanged amplitude of mIPSCs. A decrease in receptor number at existing postsynaptic sites would be predicted to change amplitude whereas a loss of postsynaptic sites would be most consistent with a change in frequency. Other mutations that have been described in the literature may produce both effects, accounting for the change in amplitude and frequency. In *unc-2(gf)* mutants there appears to be a decrease in the number of postsynaptic GABAR clusters: at some NMJs, we find presynaptic of RAB-3::mCherry puncta without punctate UNC-49::GFP apposition (Figure 6---figure supplement 3). This indicates the presence of orphan presynaptic sites and post-synaptic silencing of GABA synapses. A decrease in non-synaptic receptors could account for a reduction in UNC-49::GFP intensity without changed amplitude, but does not account for the observed reduction in mIPSC frequency. A more plausible explanation, as we outline in the text, is a decrease in the number of UNC-49-containing postsynaptic sites on the muscle arms in the ventral nerve cord. This accounts for the observed reduction in mIPSC frequency, the preserved mIPSC amplitude, and the reduced UNC49::GFP intensity in the ventral nerve cord.

> 2\) The authors conclude that unc-2(gf) mutants have decreased GABA synapse numbers, based on recordings indicating a decreased mIPSC rate. The mIPSC recordings were done in the presence of a cholinergic antagonist (dTBC), which by itself decreases mIPSC rate (since cholinergic neurons provide the excitatory input to GABA neurons). It seems possible that use of dTBC biases their results toward lower mIPSC rates. I recommend recording mIPSCs without dTBC (i.e. using a low chloride internal buffer and holding potentials of 0 mV).

We are measuring mIPSC frequency and amplitude specifically from GABAergic motor neuron (VD) synapses onto muscle. VDs are postsynaptic to cholinergic motor neurons. We include dTBC to eliminate cholinergic drive onto the VDs and isolate VD endogenous events. UNC-2(gf) is also predicted to promote cholinergic synaptic transmission onto the VDs. In the absence of dTBC, our e-phys recording would measure the compound effect of increased cholinergic drive onto VDs and VD's endogenous IPSCs. Therefore, we believe the most clear experiment is to perform the analysis in the presence of dTBC as presented. We note that we have used this strategy to clearly distinguish mEPSCs and mIPSCs in numerous prior studies.

The recommended recording -- recording mIPSCs without dTBC, with a low chloride internal buffer and holding potential of 0mV *--* has been used in several studies. We respectfully point out that this is not the only protocol used in the *C. elegans* field for recording IPSC events, and at least for us, we could not find data that demonstrated the specificity of recording conditions (data not shown in Madison, Nurrish and Kaplan, 2005).

Before applying our current electrophysiology protocol, as shown in Figure 2A-B in Maro et al. (2015), we tested the effect of holding membrane potentials and dTBCs to show that using our intracellular recording solution, at -10mV holding potential, and the in presence of 0.5mM dTBC, we blocked all EPSC events without blocking IPSC events in the muscle preparation.

For the current study, a significant increase of EPSC events (recorded in *unc-49(lf)* mutant background) in *unc2(gf)* made it more important to apply dTBC. The use of dTBC does not bias but isolate the mIPSC population from the GABAergic VD-class motor neurons in both wild-type and *unc-2(gf)* mutant for comparison.

> 3\) If lower synapse numbers occur in unc-2(gf) mutants (as the authors propose), I would expect that synaptic puncta density (both RAB-3 and UNC-49) would be reduced. The authors should report density data for the synaptic markers.

UNC-49 abundance was quantified by calculating the overall intensity of UNC-49::GFP in the region of nerve cord imaged. This is a compound measurement, dependent on the density of clusters, intensity of each cluster, and any diffuse UNC-49::GFP that is not localized to a cluster. We also measured the cluster density, and found an increase in presynaptic RAB-3 density and decreased UNC-49 density. We can include these data in a revised manuscript. These measures parallel overall intensity measurements. We didn't add the density measurements since they do not add much information to the overall intensity measurements. Our data are consistent with the interpretation that there are fewer GABAergic postsynapses, and orphan (silent) GABAergic presynapses.

> 4\) If the unc-2(gf) mIPSC rate defect cell autonomous to D neurons? If so, one would not need to propose altered cholinergic transmission in causing this phenotype (which the authors propose).

We did not do this particular experiment, but we do show extensively that the effect of *unc-2(zf35)* on ventral cord UNC-49::GFP intensity is the result of a dominant effect in cholinergic neurons. Expression of *unc-2(gf)* transgene in GABAergic neurons alone, in an otherwise wild-type background, resulted in a marked increase in UNC-49::GFP intensity, whereas specific transgene expression in cholinergic neurons decreased the intensity similar to *unc-2(gf)* mutants (see Figure 7). Furthermore, cell specific expression of an *unc-2(gf)* transgene in GABAergic neurons increases aldicarb resistance, indicating an increase in GABAergic transmission. (Expression of *unc-2(gf)* in cholinergic neurons decreases aldicarb resistance). We can include these data in a revised version of the manuscript. Together, these experiments all indicate that the reduction of mIPSC rate in *unc-2(gf)* is not cell autonomous to the D-type motor neurons and further support our conclusion that altered cholinergic transmission is responsible for the transmission defects in *unc-2(gf)*.

> 5\) No controls are provided to determine if changes in synaptic puncta intensities are caused by transcriptional changes.

We have performed transcriptional analyses but did not include these data in this manuscript. RNA-seq experiments, in which we compared wild-type vs. *unc-2(gf)* expression profiles showed no differences in *unc-49* expression but did show an increase in *unc-29* expression. We confirmed this data by qPCR. We can include these data in a revised manuscript.

> 6\) The RAB-3 puncta intensity changes are hard to interpret without further experiments. Are other SV markers altered similarly? Is the SV pool size altered (either by electrophysiology or EM)?

This is not the main point of the paper.As noted by reviewer 2 and 3, the main point of our study is to demonstrate that gain-of-function mutations, as found in FHM1 patients, result in E/I imbalance. E/I imbalance does not simply arise due to cell autonomous excitability increases in excitatory and inhibitory neurons, but arise primarily from increased excitatory signaling onto synaptic targets, in this case muscle cells. Our electrophysiology shows that there is increased excitatory input and decreased inhibitory input to ventral muscles in *unc-2(gf)*. We provide evidence that increased cholinergic signaling leads to a reduction GABAergic synapses and explain and support this with pharmacology, fluorescent imaging of pre- and postsynaptic components of excitatory and inhibitory NMJs, cell specific expression and in vitro electrophysiology, as well as the impact on circuit output using locomotory behavior as a readout.

\[Editors' note: what follows is the author responses to the first round of peer review, after they were invited to make a revised submission.\]

> Reviewer \#3:
>
> The study is in general, rigorously designed, I have the following reservations though:
>
> 1\) The effect of the novel mutation the authors identified on Ca^2+^ currents was studied by introducing the mutation in the human homolog. The authors do not mention anywhere the percentage of identity and homology between the worm and the human unc-2 type channels. This is relevant because, while the loop where the mutation is located is highly conserved, other parts of the proteins may not share such a high degree of homology and they may influence the overall effect of this mutation on the function of the channel. The experiment should really be repeated by introducing the mutation in worm unc-2.

We thank the reviewer for this comment. UNC-2 and mammalian CaV2 α1 subunit classes share a high degree of similarity. Since this was published previously (Mathews et al., 2003) we did not include in the initial version of the manuscript. We agree that this is helpful to directly compare UNC-2 and associated mutation directly with CACNA1A and now include an alignment of UNC-2 and CACNA1A in the supplemental figures (UNC-2 and CACNA1A share 68% similarity, Figure 2---figure supplement 1).

> The genetic data, and suppressor screen demonstrate that the *unc-2(zf35)* allele is a gain-of-function mutation of the CaV2α gene. We sought further evidence to demonstrate the biophysical effects on channel function in cell transfection experiments. The HEK cell electrophysiology experiments show the effect of the G to R substitution on CaV2 channel function, which is located in a highly conserved loop (Figure 2C). The main point of these experiments is to show that the G to R mutation results in a negative shift in the voltage dependence of activation, and increased current density, similar to those prior observations for CACNA1A channels that carry FHM1 mutations. The HEK cell experiments are consistent with our behavioral, electrophysiological and genetic analyses, demonstrating that UNC-2(G1132R) generates a gain-of-function phenotype. Analysis of the biophysical effect of the *zf35* mutation on the UNC-2/CaV2α channel would require the co-transfection of genes encoding the *C. elegans* ß (*ccb-1*) and α2∂ subunits (*unc-36*), and maybe other genes required for proper UNC-2 channel transport and localization *(e.g. calf-1)*. Unfortunately, no worm cell lines are available to perform these experiments. Mammalian cell lines stably transfected with ß and α2∂ subunits have been used extensively to study the effect of CaV2α mutations (including UNC-2 loss-of-function mutations; Mathews et al., 2003). This allowed us to make informative comparisons of the *zf35* mutation with those of previously characterized FHM1 mutations. The reciprocal experiment, expression of the *unc-2* transgene with corresponding human FHM1 mutations, provides strong behavioral and genetic evidence that FHM1 mutations are gain-of-function mutations.
>
> 2\) Throughout the text and in the figures, it is really hard to keep track of which gain of function mutation the authors are referring to. Is it the unc-2(gf) of the unc-2/CaV2α(gf)? Especially in light of the fact that exact parallelism between the worm and the human mutant channels function has not been firmly established, this point is particularly relevant. The authors should name the mutations throughout the text and in the figures and not simply call them unc-2(gf) mutants.

Thank you for the suggestion. We now clarified this in the text and referred to the gain-of-function *unc* allele as *unc-2(zf35gf)* throughout the manuscript. After characterization of the *unc-2(zf35gf)* allele in the manuscript we refer to the corresponding protein as UNC-2/CaV2α(GF). UNC-2(GF) is used in figures and figure legends for brevity. The FHM1 mutations in the UNC-2 are referred to by their FHM1 amino acid substitutions (UNC-2(R192Q) OR UNC-2(S218L). We hope this avoids confusion.

*3) It appears that the effect of the gain of function mutation is both on voltage dependence and either trafficking or single-channel conductance (or both, at least in expression system). Indeed, currents shown in Figure 3 were recorded under conditions of complete removal of inactivation (holding -120mV) yet the mutant currents are much larger than the wild type currents. The authors need to comment on this. The authors could also compare unc-2(wt)::GFP and unc-2(gf)::GFP to see if there is more mutant protein being expressed* in vivo.

We agree with the reviewer that the larger currents that we show for the CACNA1A(G1518R) channel could reflect increased single channel conductance, enhanced expression or both. We observed an increase in current density in independent transfection experiments in HEK cells (Figure 3). We did compare expression level, and localization of the UNC-2(WT)::GFP and UNC-2(GF)::GFP in transgenic animals (Figure 2D) and did not see any obvious differences. This suggests that the mutation, besides the change in the voltage dependence of activation, also affects conductance. We comment on these possibilities in the Discussion section.

> 4\) While the results suggest that tax-6 acts in the muscle to decrease GABAergic synapses, rescue or RNAi in muscle should confirm the conclusion of the authors.

We thank the reviewer for the suggestion. We have performed a *tax-6* RNAi feeding experiments. Neurons are largely resistant to RNAi feeding in *C. elegans* (Kammath et al., 2001; Timmons et al., 2001), tax-6 RNAi feeding rescued UNC-49::GFP fluorescence in *unc-2(zf35gf)* mutants. These experiments are included in the revised manuscript (Figure 7---figure supplement 3).

> Reviewer \#4:
>
> The authors analyze a novel gain of function (gf) allele of CaV2 N-type calcium channels. The unc-2(zf35gf) mutant was isolated in a screen for altered locomotion, lacking persistent forward or reverse movements while retaining a high level of motility. Analogous mutations in mammalian CaV2 channels expressed in tissue culture cells shows that the zf35 mutation alters channel gating (shifting activation to more negative membrane potentials and delaying inactivation). Similar gf alleles were previously described in mammalian CaV2 and CaV1 channels. Extensive analysis of unc-2(zf35) mutant worms finds changes in spontaneous cholinergic and GABAergic synaptic currents, and changes in the abundance of pre-synaptic (RAB-3) and post-synaptic (UNC-49 and UNC-29) markers. Based on these studies, the authors suggest that unc-2(zf35gf) mutants have altered GABA synapse development and that this results from the increased excitatory transmission. These conclusions are not strongly supported by the data. I agree that transmission has changed in these mutants, but it could simply be what you expect from increased UNC-2 channel currents. The analysis of unc-2(gf) mutants is extensive and would likely be of interest to C. elegans labs; however, they do not provide a clear understanding of how nervous system development or function is altered in these mutants. For these reasons, I do not support publication in eLife.

As pointed out by the reviewer 2 and 3, the main message of the paper is that gain-of-function mutation in the presynaptic voltage gated calcium channel causes an imbalance in E/I transmission. Since the *unc-2* is expressed in all neurons, this is not what would simply be expected from increased UNC-2 calcium currents. We present evidence that increased cholinergic transmission in *unc-2/CaV2α(zf35gf)* mutants leads to a reduction of GABA synapses in a TAX-6/calcineurin dependent manner. While additional detailed molecular and cellular mechanisms remain to be explored (as with any study), our data provide a deeper understanding of how alterations in Ca-channel function produce unexpected changes in E/I balance in the nervous system. Further, our analysis of FHM mutations using this model provides evidence that these mutations produce similar changes in E/I balance that have clear implications for human disease.

> Essential revisions:
>
> 1\) Post-synaptic GABA receptor abundance was significantly reduced in unc-2(gf) mutants but this was not accompanied by a corresponding decrease in the amplitude of the spontaneous IPSCs. Several prior papers found that mutations decreasing GABA receptor puncta intensities are closely matched by similar changes in IPSC current amplitudes (e.g. Maro, Tu, and Tong papers).

We understand the reviewer's point as there is currently some discrepancy in the field to what extent electrophysiological data correlate with fluorescence intensity of synaptic markers. We do believe that the reviewer's statement does not accurately represent the results from the cited papers.

Specifically, the papers cited by the reviewer did not show that decreased postsynaptic GABAR marker signals are closely matched by changes in IPSC amplitude. Instead, and consistent with our findings, these studies showed that decreased GABA receptor marker intensity is closed matched by a reduction in IPSC frequency. The IPSC amplitudes, even of the same mutant, behaved differently in different preparations, and reported changes do not strongly correlate with changes in UNC-49::GFP fluorescence.

To summarize the relevant data from these papers:

Maro et al. (2015) showed that the degree of reduction of UNC-49 puncta signals in *madd-4, nlg-1* and *nrx-1* mutants wereclosely matched by the reduction of the IPSC frequency. For example, *nlg-1* mutants exhibited strong reduction of IPSC frequency and UNC-49 signals, but *nrx-1* did not show defects in either. Here *nlg-1* mutants exhibited a very small reduction of IPSC amplitude, which did not closely match the very strong reduction in UNC-49/GABAR clustering and fluorescence.

Tu et al. (2015) reported reduction of mIPSC frequency and amplitude in these three mutants, irrespective of their different degrees of reduction of the UNC-49/GABAR fluorescence. For example, *madd-4B(0)* showed no significant change in UNC-49 intensity, but exhibited a significant reduction of IPSC frequency, and a milder reduction in amplitude.

Tong et al. (2015) reported that the *nlg-1* mutants exhibited reduced UNC-49 fluorescence signals, reduced mIPSC frequency, and reduced mIPSC amplitude. The reduction in mIPSC amplitude reported in was larger than reported in the other two studies. Tong et al., (2015) reported two other mutants (*lin-2, frm-3)* that exhibited a reduction in UNC-49/GABA receptor signals, reduced mIPSC amplitude reduction but no change in mIPSC frequency. Unlike *unc-2*, these two genes function strictly in muscles to regulate UNC-49/GABA receptor levels. In another mutant, *nrx-1*, which was also examined in the other two papers, the authors found no overt fluorescent marker change, but an increase of mIPSC amplitude and no change in frequency. The reported mIPSC amplitude changes don't follow an obvious trend with respect to changes in GABA receptor fluorescence intensity and are inconsistent across studies, even for the same mutation.

Our results for *unc-2(zf35gf)* mutants show concomitant changes of UNC-49/GABA receptor intensity and IPSC frequency, which is consistent with the most salient findings reported in the cited papers.

> Given the absence of an effect on mIPSC amplitudes, these results suggest that the GABA receptors imaged here are non-synaptic. Altered non-synaptic receptors could be interesting but would require many new experiments to prove and document a functional consequence (e.g. altered tonic GABA inhibition).

We report a decrease in UNC-49::GFP intensity in the ventral nerve cord of *unc-2(zf35)*, a decreased frequency of mIPSCs, and an unchanged amplitude of mIPSCs. A decrease in receptor number at existing postsynaptic sites would be predicted to change amplitude whereas a loss of postsynaptic sites would be most consistent with a change in frequency. Other mutations that have been described in the literature may produce both effects, accounting for the change in amplitude and frequency. In *unc2(zf35gf)* mutants there appears to be a decrease in the number of postsynaptic GABAR clusters: at some NMJs, we find presynaptic of RAB-3::mCherry puncta without punctate UNC-49::GFP apposition (Figure 6---figure supplement 3). This indicates the presence of orphan presynaptic sites and post-synaptic silencing of GABA synapses. A decrease in non-synaptic receptors could account for a reduction in UNC-49::GFP intensity without changed amplitude, but does not account for the observed reduction in mIPSC frequency. As we outline in the text, we believe that a decrease in the number of UNC-49containing postsynaptic sites on the muscle arms in the ventral nerve cord is a more plausible explanation. This accounts for the observed reduction in mIPSC frequency, the preserved mIPSC amplitude, and the reduced UNC-49::GFP intensity in the ventral nerve cord.

> 2\) The authors conclude that unc-2(gf) mutants have decreased GABA synapse numbers, based on recordings indicating a decreased mIPSC rate. The mIPSC recordings were done in the presence of a cholinergic antagonist (dTBC), which by itself decreases mIPSC rate (since cholinergic neurons provide the excitatory input to GABA neurons). It seems possible that use of dTBC biases their results toward lower mIPSC rates. I recommend recording mIPSCs without dTBC (i.e. using a low chloride internal buffer and holding potentials of 0 mV).

We are measuring mIPSC frequency and amplitude specifically from GABAergic motor neuron (VD) synapses onto muscle. VDs are postsynaptic to cholinergic motor neurons. We include dTBC to eliminate cholinergic drive onto the VDs and isolate VD endogenous events. The UNC-2(GF) channel is also predicted to promote cholinergic synaptic transmission onto the VDs. In the absence of dTBC, our electrophysiology recording would measure the compound effect of increased cholinergic drive onto VDs and VD's endogenous IPSCs. Therefore, we believe the clearest experiment is to perform the analysis in the presence of dTBC as presented. We note that we have used this strategy to clearly distinguish mEPSCs and mIPSCs in prior published studies.

The recommended recording -- recording mIPSCs without dTBC, with a low chloride internal buffer and holding potential of 0mV *--* has been used in several studies. But we respectfully point out that this is not the only protocol used in the *C. elegans* field for recording IPSC events. At least for us, we could not find published data that demonstrated the specificity of stated recording conditions. The closest we found was "data not shown" in Madison et al., 2005.

Before applying our electrophysiology protocol (Maro et al., 2015; Figure 2A-B), we tested the effect of holding membrane potentials and dTBCs to show that using our intracellular recording solution, at -10mV holding potential, and the in presence of 0.5mM dTBC, we blocked all EPSC events without blocking IPSC events in the muscle preparation.

For the current study, a significant increase of EPSC events (recorded in *unc-49(lf)* mutant background) in *unc-2(zf35gf)* made it more important to apply dTBC. The use of dTBC does not bias but isolate the mIPSC population from the GABAergic VD-class motor neurons in both wild-type and *unc-2(gf)* mutant for comparison.

> 3\) If lower synapse numbers occur in unc-2(gf) mutants (as the authors propose), I would expect that synaptic puncta density (both RAB-3 and UNC-49) would be reduced. The authors should report density data for the synaptic markers.

UNC-49 abundance was quantified by calculating the overall intensity of UNC-49::GFP in the region of nerve cord imaged. This is a compound measurement, dependent on the density of clusters, intensity of each cluster, and any diffuse UNC-49::GFP that is not localized to a cluster. We also measured the cluster density, and found an increase in presynaptic RAB-3 density and decreased UNC-49 density. We now include these data in the revised manuscript (Figure 6---figure supplement 2). These measures parallel overall intensity measurements. Our data are consistent with the interpretation that there are fewer GABAergic postsynapses, and orphan (silent) GABAergic presynapses.

> 4\) If the unc-2(gf) mIPSC rate defect cell autonomous to D neurons? If so, one would not need to propose altered cholinergic transmission in causing this phenotype (which the authors propose).

We did not do this particular experiment, but we do show extensively that the effect of *unc-2(zf35gf)* on ventral cord UNC-49::GFP intensity is the result of a dominant effect in cholinergic neurons. Expression of *unc-2(zf35gf)* transgene in GABAergic neurons alone, in an otherwise wild-type background, resulted in a marked increase in UNC-49::GFP intensity, whereas specific transgene expression in cholinergic neurons decreased the intensity similar to *unc-2(zf35gf)* mutants (see Figure 7). Furthermore, cell specific expression of an *unc-2(zf35gf)* transgene in GABAergic neurons increases aldicarb resistance, indicating an increase in GABAergic transmission. (Expression of *unc-2(zf35gf)* in cholinergic neurons decreases aldicarb resistance). We now include these data in a revised version of the manuscript (Figure 7---figure supplement 2). Together, these experiments all indicate that the reduction of mIPSC rate in *unc-2(zf35gf)* is not cell autonomous to the D-type motor neurons and further support our conclusion that altered cholinergic transmission is responsible for the transmission defects in *unc-2(zf35gf)*.

> 5\) No controls are provided to determine if changes in synaptic puncta intensities are caused by transcriptional changes.

We thank the reviewer for pointing this out. We did perform transcriptional analyses but did not include these data in this manuscript. RNA-seq experiments, in which we compared expression profiles of wild-type vs. *unc-2(zf35gf)* animals showed no significant differences in *unc-29, unc-49, myo-3, rab-3, unc-2* and *rgef-1* expression. We include these data in a revised manuscript (Figure 6---figure supplement 4).

> 6\) The RAB-3 puncta intensity changes are hard to interpret without further experiments. Are other SV markers altered similarly? Is the SV pool size altered (either by electrophysiology or EM)?

We agree that future studies are needed to provide additional mechanistic insights. However, this is not the main point of the paper.As noted by reviewer 2 and 3, the main point of our study is to demonstrate that gain-of-function mutations, as found in FHM1 patients, result in E/I imbalance. E/I imbalance does not simply arise due to cell autonomous excitability increases in excitatory and inhibitory neurons, but arise primarily from increased excitatory signalling onto synaptic targets, in this case muscle cells. Our electrophysiology shows that there is increased excitatory input and decreased inhibitory input to ventral muscles in *unc-2(zf35gf)*. We provide evidence that increased cholinergic signalling leads to a reduction GABAergic synapses and explain and support this with pharmacology, fluorescent imaging of pre- and postsynaptic components of excitatory and inhibitory NMJs, cell specific expression and in vitro electrophysiology, as well as the impact on circuit output using locomotory behavior as a readout.
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